| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity | 5.90e-08 | 5 | 210 | 4 | GO:0047115 | |
| GeneOntologyMolecularFunction | 5alpha-androstane-3beta,17beta-diol dehydrogenase activity | 8.05e-07 | 8 | 210 | 4 | GO:0047024 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase activity | 8.05e-07 | 8 | 210 | 4 | GO:0047023 | |
| GeneOntologyMolecularFunction | androstan-3-alpha,17-beta-diol dehydrogenase activity | 1.44e-06 | 9 | 210 | 4 | GO:0047044 | |
| GeneOntologyMolecularFunction | bile acid binding | 2.38e-06 | 10 | 210 | 4 | GO:0032052 | |
| GeneOntologyMolecularFunction | testosterone 17-beta-dehydrogenase (NADP+) activity | 2.38e-06 | 10 | 210 | 4 | GO:0047045 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase [NAD(P)+] activity | 3.70e-06 | 11 | 210 | 4 | GO:0030283 | |
| GeneOntologyMolecularFunction | chlordecone reductase activity | 4.55e-06 | 4 | 210 | 3 | GO:0047743 | |
| GeneOntologyMolecularFunction | androsterone dehydrogenase (B-specific) activity | 4.55e-06 | 4 | 210 | 3 | GO:0047042 | |
| GeneOntologyMolecularFunction | ketoreductase activity | 4.55e-06 | 4 | 210 | 3 | GO:0045703 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 6.74e-06 | 26 | 210 | 5 | GO:0004022 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 8.05e-06 | 127 | 210 | 9 | GO:0016616 | |
| GeneOntologyMolecularFunction | 17-beta-ketosteroid reductase (NADPH) activity | 1.13e-05 | 5 | 210 | 3 | GO:0072555 | |
| GeneOntologyMolecularFunction | lithocholic acid binding | 1.13e-05 | 5 | 210 | 3 | GO:1902121 | |
| GeneOntologyMolecularFunction | Delta4-3-oxosteroid 5beta-reductase activity | 1.13e-05 | 5 | 210 | 3 | GO:0047787 | |
| GeneOntologyMolecularFunction | 15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity | 1.13e-05 | 5 | 210 | 3 | GO:0047020 | |
| GeneOntologyMolecularFunction | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity | 1.13e-05 | 5 | 210 | 3 | GO:0047006 | |
| GeneOntologyMolecularFunction | ketosteroid monooxygenase activity | 1.13e-05 | 5 | 210 | 3 | GO:0047086 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 1.41e-05 | 30 | 210 | 5 | GO:0018455 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 1.58e-05 | 138 | 210 | 9 | GO:0016614 | |
| GeneOntologyMolecularFunction | geranylgeranyl reductase activity | 2.24e-05 | 6 | 210 | 3 | GO:0045550 | |
| GeneOntologyMolecularFunction | 17-beta-hydroxysteroid dehydrogenase (NADP+) activity | 3.89e-05 | 7 | 210 | 3 | GO:0072582 | |
| GeneOntologyMolecularFunction | estradiol 17-beta-dehydrogenase [NAD(P)+] activity | 5.05e-05 | 20 | 210 | 4 | GO:0004303 | |
| GeneOntologyMolecularFunction | enone reductase activity | 6.18e-05 | 8 | 210 | 3 | GO:0035671 | |
| GeneOntologyMolecularFunction | testosterone dehydrogenase (NAD+) activity | 9.19e-05 | 9 | 210 | 3 | GO:0047035 | |
| GeneOntologyMolecularFunction | NADP+ binding | 9.19e-05 | 9 | 210 | 3 | GO:0070401 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 1.07e-04 | 24 | 210 | 4 | GO:0004745 | |
| GeneOntologyMolecularFunction | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity | 1.10e-04 | 2 | 210 | 2 | GO:0016404 | |
| GeneOntologyMolecularFunction | NADPH binding | 1.48e-04 | 26 | 210 | 4 | GO:0070402 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | TRIO PAK4 NME9 AK3 JAK3 KARS1 RPS6KA6 POLN PLK3 MOK NAGK NTRK2 TUT7 POLR2B LRRK1 MTOR STK33 PKN1 TNKS PRKCZ MAPK13 SBK3 | 3.77e-04 | 938 | 210 | 22 | GO:0016772 |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 3.83e-04 | 33 | 210 | 4 | GO:0033764 | |
| GeneOntologyMolecularFunction | aldose reductase (NADPH) activity | 3.83e-04 | 14 | 210 | 3 | GO:0004032 | |
| GeneOntologyMolecularFunction | retinal dehydrogenase activity | 3.83e-04 | 14 | 210 | 3 | GO:0001758 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor | 4.31e-04 | 34 | 210 | 4 | GO:0016628 | |
| GeneOntologyMolecularFunction | protein serine kinase activity | TRIO PAK4 RPS6KA6 PLK3 MOK LRRK1 MTOR STK33 PKN1 PRKCZ MAPK13 SBK3 | 4.85e-04 | 363 | 210 | 12 | GO:0106310 |
| GeneOntologyMolecularFunction | microfilament motor activity | 6.63e-04 | 38 | 210 | 4 | GO:0000146 | |
| GeneOntologyMolecularFunction | steroid dehydrogenase activity | 7.33e-04 | 39 | 210 | 4 | GO:0016229 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC4 MYH10 MYH11 MYO1E MCM3 MDN1 ASCC3 RAD54L HSP90AA2P HSP90AB3P DHX58 MSH2 FIGN ATP10D MYH15 DNAH11 | 8.13e-04 | 614 | 210 | 16 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCC4 MYO1E MCM3 MDN1 ASCC3 RAD54L HSP90AA2P HSP90AB3P DHX58 MSH2 FIGN ATP10D DNAH11 | 8.31e-04 | 441 | 210 | 13 | GO:0016887 |
| GeneOntologyMolecularFunction | organic acid binding | 1.52e-03 | 254 | 210 | 9 | GO:0043177 | |
| GeneOntologyMolecularFunction | 3',5'-cyclic-AMP phosphodiesterase activity | 1.52e-03 | 22 | 210 | 3 | GO:0004115 | |
| GeneOntologyMolecularFunction | histone H3K4me/H3K4me2/H3K4me3 demethylase activity | 1.61e-03 | 6 | 210 | 2 | GO:0034647 | |
| GeneOntologyMolecularFunction | actin binding | MYH10 MYH11 MYO1E SPTAN1 FXYD5 PLEC SETD3 PICK1 VASH1 P4HB MYH15 TNS4 KLHL17 | 1.74e-03 | 479 | 210 | 13 | GO:0003779 |
| GeneOntologyMolecularFunction | 3',5'-cyclic-GMP phosphodiesterase activity | 1.97e-03 | 24 | 210 | 3 | GO:0047555 | |
| GeneOntologyMolecularFunction | small GTPase binding | KCTD13 NCKAP1 TSC2 CYRIA RGPD2 RAB11FIP1 EXOC8 DOCK7 PKN1 FGD6 | 2.20e-03 | 321 | 210 | 10 | GO:0031267 |
| GeneOntologyMolecularFunction | 3',5'-cyclic-nucleotide phosphodiesterase activity | 2.22e-03 | 25 | 210 | 3 | GO:0004114 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NADP+) activity | 2.78e-03 | 27 | 210 | 3 | GO:0008106 | |
| GeneOntologyMolecularFunction | cyclic-nucleotide phosphodiesterase activity | 2.78e-03 | 27 | 210 | 3 | GO:0004112 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | TRIO PAK4 RPS6KA6 PLK3 MOK LRRK1 MTOR STK33 PKN1 PRKCZ MAPK13 SBK3 | 2.79e-03 | 446 | 210 | 12 | GO:0004674 |
| GeneOntologyMolecularFunction | actin filament binding | 2.84e-03 | 227 | 210 | 8 | GO:0051015 | |
| GeneOntologyMolecularFunction | histone H3K4 demethylase activity | 2.96e-03 | 8 | 210 | 2 | GO:0032453 | |
| GeneOntologyMolecularFunction | kinase activity | TRIO PAK4 NME9 AK3 JAK3 RPS6KA6 PLK3 MOK NAGK NTRK2 LRRK1 MTOR STK33 PKN1 PRKCZ MAPK13 SBK3 | 3.03e-03 | 764 | 210 | 17 | GO:0016301 |
| GeneOntologyBiologicalProcess | daunorubicin metabolic process | 1.19e-06 | 9 | 207 | 4 | GO:0044597 | |
| GeneOntologyBiologicalProcess | doxorubicin metabolic process | 1.97e-06 | 10 | 207 | 4 | GO:0044598 | |
| GeneOntologyBiologicalProcess | polyketide metabolic process | 1.97e-06 | 10 | 207 | 4 | GO:0030638 | |
| GeneOntologyBiologicalProcess | aminoglycoside antibiotic metabolic process | 1.97e-06 | 10 | 207 | 4 | GO:0030647 | |
| GeneOntologyBiologicalProcess | glycoside metabolic process | 2.22e-06 | 22 | 207 | 5 | GO:0016137 | |
| GeneOntologyBiologicalProcess | response to jasmonic acid | 3.96e-06 | 4 | 207 | 3 | GO:0009753 | |
| GeneOntologyBiologicalProcess | progesterone catabolic process | 3.96e-06 | 4 | 207 | 3 | GO:0006709 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone catabolic process | 3.96e-06 | 4 | 207 | 3 | GO:0008208 | |
| GeneOntologyBiologicalProcess | cellular response to jasmonic acid stimulus | 3.96e-06 | 4 | 207 | 3 | GO:0071395 | |
| GeneOntologyBiologicalProcess | sesquiterpenoid catabolic process | 9.82e-06 | 5 | 207 | 3 | GO:0016107 | |
| GeneOntologyBiologicalProcess | olefinic compound catabolic process | 9.82e-06 | 5 | 207 | 3 | GO:0120256 | |
| GeneOntologyBiologicalProcess | farnesol metabolic process | 9.82e-06 | 5 | 207 | 3 | GO:0016487 | |
| GeneOntologyBiologicalProcess | farnesol catabolic process | 9.82e-06 | 5 | 207 | 3 | GO:0016488 | |
| GeneOntologyBiologicalProcess | negative regulation of isoprenoid metabolic process | 9.82e-06 | 5 | 207 | 3 | GO:0045827 | |
| GeneOntologyBiologicalProcess | negative regulation of retinoic acid biosynthetic process | 9.82e-06 | 5 | 207 | 3 | GO:1900053 | |
| GeneOntologyBiologicalProcess | response to X-ray | 1.13e-05 | 30 | 207 | 5 | GO:0010165 | |
| GeneOntologyBiologicalProcess | negative regulation of hormone metabolic process | 1.63e-05 | 16 | 207 | 4 | GO:0032351 | |
| GeneOntologyBiologicalProcess | circulatory system development | MYH10 MYH11 NCKAP1 MYO1E IFT172 PAK4 TSC2 SVEP1 RYR2 STAB1 JUP HPGD FGF9 VAV3 PLEC CPLANE1 HECTD1 GPLD1 MIA3 PDCD6 ANXA3 NTRK2 VASH1 OBSL1 MTOR VWA5A SLITRK5 LRP2 MMRN2 EP300 PCNT DNAH11 | 1.89e-05 | 1442 | 207 | 32 | GO:0072359 |
| GeneOntologyBiologicalProcess | sesquiterpenoid metabolic process | 1.95e-05 | 6 | 207 | 3 | GO:0006714 | |
| GeneOntologyBiologicalProcess | polyprenol catabolic process | 1.95e-05 | 6 | 207 | 3 | GO:0016095 | |
| GeneOntologyBiologicalProcess | response to prostaglandin D | 3.38e-05 | 7 | 207 | 3 | GO:0071798 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin D stimulus | 3.38e-05 | 7 | 207 | 3 | GO:0071799 | |
| GeneOntologyBiologicalProcess | regulation of retinoic acid biosynthetic process | 3.38e-05 | 7 | 207 | 3 | GO:1900052 | |
| GeneOntologyBiologicalProcess | response to radiation | PDE6B IKBIP KARS1 FECH PLK3 RAD54L CACNB4 TOPBP1 MSH2 LIG4 ARRB1 MTOR PDE8B LRP2 MAPK13 EP300 | 5.15e-05 | 503 | 207 | 16 | GO:0009314 |
| GeneOntologyBiologicalProcess | hormone catabolic process | 5.16e-05 | 21 | 207 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | ketone catabolic process | 5.16e-05 | 21 | 207 | 4 | GO:0042182 | |
| GeneOntologyBiologicalProcess | parturition | 6.26e-05 | 22 | 207 | 4 | GO:0007567 | |
| GeneOntologyBiologicalProcess | tertiary alcohol metabolic process | 6.26e-05 | 22 | 207 | 4 | GO:1902644 | |
| GeneOntologyBiologicalProcess | cellular response to prostaglandin stimulus | 7.51e-05 | 23 | 207 | 4 | GO:0071379 | |
| GeneOntologyBiologicalProcess | regulation of isoprenoid metabolic process | 1.13e-04 | 10 | 207 | 3 | GO:0019747 | |
| GeneOntologyBiologicalProcess | negative regulation of vitamin metabolic process | 1.13e-04 | 10 | 207 | 3 | GO:0046137 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol 3-kinase/protein kinase B signal transduction | INPP5K TSC2 AKR1C4 AKR1C1 VAV3 PLK3 PDCD6 NTRK2 SESN3 MTOR CD28 LRP2 AKR1C3 | 1.36e-04 | 382 | 207 | 13 | GO:0043491 |
| GeneOntologyBiologicalProcess | cellular response to hormone stimulus | ACACA INHBB INPP5K TSC2 AKR1C4 KDM5D AKR1C1 JAK3 LPIN1 FECH RAB13 GPLD1 NTRK2 SESN3 MTOR AKR1C3 PKN1 PRKCZ EP300 | 1.41e-04 | 727 | 207 | 19 | GO:0032870 |
| GeneOntologyBiologicalProcess | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | INPP5K TSC2 AKR1C4 AKR1C1 VAV3 PLK3 PDCD6 NTRK2 SESN3 MTOR CD28 AKR1C3 | 1.49e-04 | 334 | 207 | 12 | GO:0051896 |
| GeneOntologyBiologicalProcess | regulation of testosterone biosynthetic process | 1.55e-04 | 11 | 207 | 3 | GO:2000224 | |
| GeneOntologyBiologicalProcess | terpenoid catabolic process | 1.55e-04 | 11 | 207 | 3 | GO:0016115 | |
| GeneOntologyBiologicalProcess | response to calcium ion | 2.27e-04 | 161 | 207 | 8 | GO:0051592 | |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | PDE6B TSC2 IKBIP RYR2 JUP KARS1 FECH PLEC PLK3 RAD54L PICK1 HSP90AA2P HSP90AB3P GPLD1 CACNB4 PDCD6 NGB TOPBP1 MSH2 LIG4 ARRB1 P4HB MTOR PDE8B LRP2 PKN1 MAPK13 EP300 | 2.37e-04 | 1361 | 207 | 28 | GO:0009628 |
| GeneOntologyBiologicalProcess | cellular response to L-leucine | 2.65e-04 | 13 | 207 | 3 | GO:0071233 | |
| GeneOntologyBiologicalProcess | regulation of hormone metabolic process | 2.89e-04 | 58 | 207 | 5 | GO:0032350 | |
| GeneOntologyBiologicalProcess | retinoic acid biosynthetic process | 3.34e-04 | 14 | 207 | 3 | GO:0002138 | |
| GeneOntologyBiologicalProcess | isoprenoid catabolic process | 3.34e-04 | 14 | 207 | 3 | GO:0008300 | |
| GeneOntologyBiologicalProcess | peptidyl-amino acid modification | INPP5K JAK3 NAA35 RPS6KA6 NKTR TTLL10 SETD3 LILRA5 RGPD2 NTRK2 LRRK1 PPEF2 ARRB1 P4HB MTOR DOCK7 PKN1 TNKS TMEM102 PRKCZ MAPK13 EP300 | 3.42e-04 | 976 | 207 | 22 | GO:0018193 |
| GeneOntologyBiologicalProcess | cellular response to alcohol | 3.45e-04 | 130 | 207 | 7 | GO:0097306 | |
| GeneOntologyBiologicalProcess | actin filament-based process | MYH10 MYH11 KCTD13 NCKAP1 MYO1E INPP5K SPTAN1 RYR2 LPIN1 CYRIA JUP PLEC SETD3 RAB13 PICK1 OBSL1 ARRB1 MTOR FGD6 EP300 KLHL17 | 3.54e-04 | 912 | 207 | 21 | GO:0030029 |
| GeneOntologyBiologicalProcess | steroid catabolic process | 3.61e-04 | 34 | 207 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | diterpenoid biosynthetic process | 4.15e-04 | 15 | 207 | 3 | GO:0016102 | |
| GeneOntologyBiologicalProcess | glycosyl compound metabolic process | 4.16e-04 | 96 | 207 | 6 | GO:1901657 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | ABCC4 MYH10 NCKAP1 IFT172 INPP5K FXYD5 CFAP65 CFAP54 VAV3 CPLANE1 CFAP43 CEP164 CELSR3 CEP89 MTOR FGD6 PCNT | 4.47e-04 | 670 | 207 | 17 | GO:0120031 |
| GeneOntologyBiologicalProcess | response to prostaglandin | 4.51e-04 | 36 | 207 | 4 | GO:0034694 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | MYH10 MYH11 KCTD13 NCKAP1 MYO1E INPP5K SPTAN1 LPIN1 CYRIA PLEC SETD3 RAB13 PICK1 OBSL1 ARRB1 MTOR FGD6 EP300 KLHL17 | 4.90e-04 | 803 | 207 | 19 | GO:0030036 |
| GeneOntologyBiologicalProcess | testosterone biosynthetic process | 5.07e-04 | 16 | 207 | 3 | GO:0061370 | |
| GeneOntologyBiologicalProcess | response to L-leucine | 5.07e-04 | 16 | 207 | 3 | GO:0043201 | |
| GeneOntologyBiologicalProcess | cell projection assembly | ABCC4 MYH10 NCKAP1 IFT172 INPP5K FXYD5 CFAP65 CFAP54 VAV3 CPLANE1 CFAP43 CEP164 CELSR3 CEP89 MTOR FGD6 PCNT | 5.73e-04 | 685 | 207 | 17 | GO:0030031 |
| GeneOntologyBiologicalProcess | establishment of viral latency | 5.93e-04 | 4 | 207 | 2 | GO:0019043 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | DLG5 RTN4R TSC2 KCTD11 TTC3 LPIN1 NTRK2 OBSL1 LGI4 LIG4 MTOR DOCK7 SLITRK5 LRP2 GOLGA8A EP300 | 5.97e-04 | 625 | 207 | 16 | GO:0051960 |
| GeneOntologyBiologicalProcess | actomyosin structure organization | 7.18e-04 | 239 | 207 | 9 | GO:0031032 | |
| GeneOntologyBiologicalProcess | regulation of vitamin metabolic process | 7.27e-04 | 18 | 207 | 3 | GO:0030656 | |
| MousePheno | decreased cell chemotaxis | 5.52e-06 | 11 | 163 | 4 | MP:0011825 | |
| MousePheno | increased circulating progesterone level | 2.20e-05 | 15 | 163 | 4 | MP:0005186 | |
| MousePheno | long gestation period | 2.20e-05 | 15 | 163 | 4 | MP:0002293 | |
| MousePheno | abnormal parturition | 3.69e-05 | 33 | 163 | 5 | MP:0002907 | |
| MousePheno | abnormal gestational length | 4.80e-05 | 18 | 163 | 4 | MP:0002292 | |
| MousePheno | abnormal atrioventricular septum morphology | 6.88e-05 | 87 | 163 | 7 | MP:0010592 | |
| MousePheno | microphthalmia | DLG5 SPTAN1 FAF2 HECTD1 ANKRD52 AGPS FIGN LGI4 RAX LRP2 CDH10 EP300 PCNT DNAH11 | 8.75e-05 | 362 | 163 | 14 | MP:0001297 |
| MousePheno | abnormal eye size | DLG5 SPTAN1 FAF2 HECTD1 ANKRD52 AGPS FIGN LGI4 RAX LRP2 CDH10 EP300 PCNT DNAH11 | 1.27e-04 | 375 | 163 | 14 | MP:0002697 |
| MousePheno | increased circulating renin level | 1.33e-04 | 23 | 163 | 4 | MP:0003352 | |
| Domain | P-loop_NTPase | GIMAP4 DLG5 ABCC4 MYH10 MYH11 MYO1E MCM3 AK3 MDN1 GNA12 ASCC3 PARPBP RAB13 RAD54L CACNB1 CACNB4 DHX58 MSH2 LRRK1 FIGN SBNO2 MYH15 DNAH11 | 7.02e-05 | 848 | 207 | 23 | IPR027417 |
| Domain | - | 1.07e-04 | 9 | 207 | 3 | 3.30.450.40 | |
| Domain | GAF_dom-like | 1.07e-04 | 9 | 207 | 3 | IPR029016 | |
| Domain | ALDOKETO_REDUCTASE_1 | 1.52e-04 | 10 | 207 | 3 | PS00798 | |
| Domain | ALDOKETO_REDUCTASE_2 | 1.52e-04 | 10 | 207 | 3 | PS00062 | |
| Domain | ALDOKETO_REDUCTASE_3 | 1.52e-04 | 10 | 207 | 3 | PS00063 | |
| Domain | Aldo/ket_reductase_CS | 1.52e-04 | 10 | 207 | 3 | IPR018170 | |
| Domain | Aldo/keto_reductase | 1.52e-04 | 10 | 207 | 3 | IPR020471 | |
| Domain | Vps51 | 3.64e-04 | 3 | 207 | 2 | IPR014812 | |
| Domain | Myosin_N | 5.53e-04 | 15 | 207 | 3 | PF02736 | |
| Domain | Myosin_N | 5.53e-04 | 15 | 207 | 3 | IPR004009 | |
| Domain | IQ | 5.90e-04 | 93 | 207 | 6 | PS50096 | |
| Domain | - | GIMAP4 DLG5 ABCC4 MYO1E MCM3 AK3 MDN1 GNA12 ASCC3 RAB13 RAD54L CACNB1 CACNB4 DHX58 MSH2 LRRK1 FIGN SBNO2 DNAH11 | 6.62e-04 | 746 | 207 | 19 | 3.40.50.300 |
| Domain | - | 6.75e-04 | 16 | 207 | 3 | 3.20.20.100 | |
| Domain | VDCC_L_bsu | 7.23e-04 | 4 | 207 | 2 | IPR000584 | |
| Domain | Lys_sp_deMease-like_dom | 7.23e-04 | 4 | 207 | 2 | IPR013637 | |
| Domain | PLU-1 | 7.23e-04 | 4 | 207 | 2 | PF08429 | |
| Domain | VGCC_beta4Aa_N | 7.23e-04 | 4 | 207 | 2 | PF12052 | |
| Domain | Myosin_head_motor_dom | 8.05e-04 | 38 | 207 | 4 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 8.05e-04 | 38 | 207 | 4 | PS51456 | |
| Domain | Myosin_head | 8.05e-04 | 38 | 207 | 4 | PF00063 | |
| Domain | MYSc | 8.05e-04 | 38 | 207 | 4 | SM00242 | |
| Domain | NADP_OxRdtase_dom | 8.14e-04 | 17 | 207 | 3 | IPR023210 | |
| Domain | Aldo_ket_red | 8.14e-04 | 17 | 207 | 3 | PF00248 | |
| Domain | Aldo/ket_red/Kv-b | 8.14e-04 | 17 | 207 | 3 | IPR001395 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | NCKAP1 MYO1E IFT172 PAK4 STYXL2 MCM3 TSC2 IKBIP KARS1 USH1G FECH TRAPPC4 PYGL NKTR PLEC VPS51 TSPYL4 CLUH HSP90AB3P OBSL1 MSH2 RAB11FIP1 EXOC8 ACTR1B OXA1L P4HB MTOR DOCK7 TMEM102 FGD6 | 5.49e-10 | 1321 | 211 | 30 | 27173435 |
| Pubmed | MYH10 ACACA NCKAP1 USP11 SPTAN1 ZNF318 KARS1 MDN1 PYGL PLEC ASCC3 HECTD1 ANKRD52 CLUH TUT7 MSH2 LMNB2 P4HB MTOR DOCK7 PCNT | 6.59e-10 | 653 | 211 | 21 | 22586326 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ACACA MYO1E TRIO CC2D1A TSC2 TTC3 BAP1 JAK3 SARS2 MDN1 GNA12 PLEC HECTD1 PLK3 PICK1 HECTD4 LMNB2 CFAP43 LRRK1 SBNO2 CELSR3 MTOR PKN1 EP300 PCNT KLHL17 | 4.19e-09 | 1105 | 211 | 26 | 35748872 |
| Pubmed | MYH10 NCKAP1 TRIO SPTAN1 MCM3 TSC2 ZNF318 TTC3 MDN1 RGPD2 CACNB1 CACNB4 MIA3 NTRK2 HECTD4 LMNB2 MTOR DOCK7 PKN1 TNKS SLC4A4 GOLGA8A CDH10 PCNT | 5.79e-09 | 963 | 211 | 24 | 28671696 | |
| Pubmed | 6.55e-09 | 5 | 211 | 4 | 17872381 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | MYH10 MYH11 ACACA TRIO PLEC ASCC3 HECTD1 TUT7 MSH2 MTOR DOCK7 | 4.98e-08 | 202 | 211 | 11 | 33005030 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | DLG5 ACACA NCKAP1 TRIO SPTAN1 PAK4 CCDC18 CC2D1A TSC2 JUP MDN1 PLEC HECTD1 MTMR12 RAB11FIP1 RFX7 CEP89 MTOR DOCK7 TMEM102 FGD6 | 7.89e-08 | 861 | 211 | 21 | 36931259 |
| Pubmed | 9.04e-08 | 8 | 211 | 4 | 20837989 | ||
| Pubmed | 2.20e-07 | 3 | 211 | 3 | 7626489 | ||
| Pubmed | MYO1E TRIO USP11 IFT172 SPTAN1 TSC2 TTC3 STAB1 CYRIA SARS2 PLEC WDR17 HECTD1 PICK1 NAGK HECTD4 OBSL1 SESN3 ARRB1 CELSR3 LRP2 AKR1C3 TNKS EP300 PCNT | 3.22e-07 | 1285 | 211 | 25 | 35914814 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | MYH11 NCKAP1 TSC2 RTN2 NAA35 KARS1 FAF2 TTC13 ASCC3 VPS51 HECTD1 MIA3 TUT7 POLR2B OBSL1 LMBR1 MSH2 LMNB2 EXOC8 LRIG1 MTOR | 3.47e-07 | 942 | 211 | 21 | 31073040 |
| Pubmed | MYH10 SPTAN1 CC2D1A LPIN1 CYRIA JUP KARS1 PLEC MIA3 LMNB2 P4HB MMRN2 PCNT | 3.63e-07 | 360 | 211 | 13 | 33111431 | |
| Pubmed | MYH10 ACACA NCKAP1 IFT172 SPTAN1 MCM3 KARS1 MDN1 FAF2 PLEC ASCC3 HECTD1 POLR2B MSH2 LMNB2 P4HB MTOR | 4.30e-07 | 638 | 211 | 17 | 33239621 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | USP11 IFT172 CC2D1A FAF2 PYGL TTC13 ASCC3 HECTD1 ANKRD52 CLUH HSP90AB3P MTMR12 NAGK ANXA3 OBSL1 MSH2 EXOC8 P4HB MTOR STYXL1 TNKS | 5.95e-07 | 974 | 211 | 21 | 28675297 |
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 10393440 | ||
| Pubmed | Mouse Akr1cl gene product is a prostaglandin D2 11-ketoreductase with strict substrate specificity. | 8.77e-07 | 4 | 211 | 3 | 31479646 | |
| Pubmed | The TSC-mTOR signaling pathway regulates the innate inflammatory response. | 8.77e-07 | 4 | 211 | 3 | 18848473 | |
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 10702227 | ||
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 17442338 | ||
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 28329705 | ||
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 16511129 | ||
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 15222881 | ||
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 10526179 | ||
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 21521174 | ||
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 8274401 | ||
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 10803568 | ||
| Pubmed | AKR1C1 alleviates LPS‑induced ALI in mice by activating the JAK2/STAT3 signaling pathway. | 8.77e-07 | 4 | 211 | 3 | 34590152 | |
| Pubmed | Structure and activity of the murine type 5 17beta-hydroxysteroid dehydrogenase gene(1). | 8.77e-07 | 4 | 211 | 3 | 10500239 | |
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 19487289 | ||
| Pubmed | Cloning and chromosomal localization of mouse 20alpha-hydroxysteroid dehydrogenase gene. | 8.77e-07 | 4 | 211 | 3 | 14967952 | |
| Pubmed | Localization of 20alpha-hydroxysteroid dehydrogenase mRNA in mouse brain by in situ hybridization. | 8.77e-07 | 4 | 211 | 3 | 15193432 | |
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 16191478 | ||
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 15577209 | ||
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 17034817 | ||
| Pubmed | RECON-Dependent Inflammation in Hepatocytes Enhances Listeria monocytogenes Cell-to-Cell Spread. | 8.77e-07 | 4 | 211 | 3 | 29764944 | |
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 17888864 | ||
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 19237748 | ||
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 28259989 | ||
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 7789999 | ||
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 20124700 | ||
| Pubmed | Enzymatic properties of a member (AKR1C20) of the aldo-keto reductase family. | 8.77e-07 | 4 | 211 | 3 | 16508162 | |
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 25476905 | ||
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 17629694 | ||
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 16018803 | ||
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 17272929 | ||
| Pubmed | Involvement of 20alpha-hydroxysteroid dehydrogenase in the maintenance of pregnancy in mice. | 8.77e-07 | 4 | 211 | 3 | 18667791 | |
| Pubmed | DLG5 USP11 SPTAN1 PAK4 CCDC18 CC2D1A TTC3 IKBIP JUP NAA35 SARS2 MDN1 FAF2 TTC13 ASCC3 ANKRD52 CLUH MIA3 POLR2B OBSL1 LMNB2 RAB11FIP1 OXA1L CEP89 P4HB PCNT | 1.37e-06 | 1487 | 211 | 26 | 33957083 | |
| Pubmed | MYH10 TRIO SPTAN1 PAK4 CCDC18 GABARAP KARS1 FECH PPP1R37 ANKRD52 MTMR12 MIA3 POLR2B MSH2 HID1 RAB11FIP1 PPEF2 CEP89 P4HB STYXL1 PCNT | 1.93e-06 | 1049 | 211 | 21 | 27880917 | |
| Pubmed | 2.18e-06 | 5 | 211 | 3 | 7737980 | ||
| Pubmed | 2.18e-06 | 5 | 211 | 3 | 38788959 | ||
| Pubmed | 2.18e-06 | 5 | 211 | 3 | 18003893 | ||
| Pubmed | Retinaldehyde is a substrate for human aldo-keto reductases of the 1C subfamily. | 2.18e-06 | 5 | 211 | 3 | 21851338 | |
| Pubmed | 2.18e-06 | 5 | 211 | 3 | 11980879 | ||
| Pubmed | Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis. | 2.18e-06 | 5 | 211 | 3 | 16984997 | |
| Pubmed | Mouse 3alpha-hydroxysteroid dehydrogenase mRNA: a marker of lung maturity. | 2.18e-06 | 5 | 211 | 3 | 17064890 | |
| Pubmed | 2.18e-06 | 5 | 211 | 3 | 10672042 | ||
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | ACACA MDN1 RPS6KA6 PLEC RAD54L ZSCAN5A POLR2B HECTD4 ZSCAN5B LRIG1 EP300 KLHL17 | 2.57e-06 | 363 | 211 | 12 | 14691545 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MYH10 ACACA NCKAP1 USP11 SPTAN1 MCM3 JUP NAA35 KARS1 MDN1 FAF2 PPP1R37 PYGL PLEC ASCC3 ANKRD52 RAB13 TUT7 POLR2B MSH2 LMNB2 AGPS ACTR1B P4HB | 2.82e-06 | 1353 | 211 | 24 | 29467282 |
| Pubmed | PAK4 ZNF318 AKR1C4 TTC3 AKR1C1 IKBIP JUP SCML2 FECH PLEC CPLANE1 PARPBP MIA3 TUT7 POLR2B SBNO2 P4HB LRP2 AKR1C3 PRKCZ PCNT | 3.21e-06 | 1084 | 211 | 21 | 11544199 | |
| Pubmed | 4.34e-06 | 6 | 211 | 3 | 19273550 | ||
| Pubmed | 4.34e-06 | 6 | 211 | 3 | 15471942 | ||
| Pubmed | MEF2 and NR2F2 cooperate to regulate Akr1c14 gene expression in mouse MA-10 Leydig cells. | 4.34e-06 | 6 | 211 | 3 | 26748576 | |
| Pubmed | 4.34e-06 | 6 | 211 | 3 | 17122075 | ||
| Pubmed | The Gαq/11-provoked induction of Akr1c18 in murine luteal cells is mediated by phospholipase C. | 4.34e-06 | 6 | 211 | 3 | 29107092 | |
| Pubmed | 4.34e-06 | 6 | 211 | 3 | 15860270 | ||
| Pubmed | Decidual prolactin silences the expression of genes detrimental to pregnancy. | 4.34e-06 | 6 | 211 | 3 | 17255200 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | DLG5 MYH10 ACACA NCKAP1 TRIO MCM3 CC2D1A PLEC CPLANE1 ANKRD52 MIA3 TUT7 POLR2B RNF135 CEP164 ACTR1B LRP2 PCNT | 5.29e-06 | 853 | 211 | 18 | 28718761 |
| Pubmed | FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells. | 6.51e-06 | 212 | 211 | 9 | 33462405 | |
| Pubmed | DLG5 ACACA MCM3 JUP KARS1 MDN1 FAF2 CLUH MIA3 POLR2B MSH2 DOCK7 | 6.73e-06 | 399 | 211 | 12 | 37536630 | |
| Pubmed | 7.57e-06 | 7 | 211 | 3 | 33127481 | ||
| Pubmed | 7.57e-06 | 7 | 211 | 3 | 12562828 | ||
| Pubmed | 7.57e-06 | 7 | 211 | 3 | 22529366 | ||
| Pubmed | 7.57e-06 | 7 | 211 | 3 | 26160177 | ||
| Pubmed | Aldo-ketoreductase 1c19 ablation does not affect insulin secretion in murine islets. | 7.57e-06 | 7 | 211 | 3 | 34843575 | |
| Pubmed | 7.57e-06 | 7 | 211 | 3 | 16337335 | ||
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | GIMAP4 ACACA SIDT1 SVEP1 STAB1 CPLANE1 PCDHGA11 NTRK2 VASH1 DENND3 PDE8B STYXL1 TNS4 DNAH11 | 8.07e-06 | 552 | 211 | 14 | 10737800 |
| Pubmed | 8.17e-06 | 118 | 211 | 7 | 30979931 | ||
| Pubmed | MYH10 MYH11 SPTAN1 PAK4 JUP VAV3 NKTR PLEC CPLANE1 ARRB1 PRKCZ SLC4A4 EP300 | 9.75e-06 | 486 | 211 | 13 | 20936779 | |
| Pubmed | 1.17e-05 | 288 | 211 | 10 | 23383273 | ||
| Pubmed | 1.19e-05 | 83 | 211 | 6 | 9039502 | ||
| Pubmed | 1.21e-05 | 8 | 211 | 3 | 33584538 | ||
| Pubmed | 1.21e-05 | 8 | 211 | 3 | 9224647 | ||
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | MYH10 ACACA NCKAP1 USP11 INPP5K PAK4 GABARAP MCM3 TSC2 FANCC JUP SARS2 FAF2 POLR2B MSH2 LRRK1 RAB11FIP1 LIG4 ARRB1 P4HB STYXL1 TMEM102 | 1.28e-05 | 1284 | 211 | 22 | 17353931 |
| Pubmed | USP45 and Spindly are part of the same complex implicated in cell migration. | 1.49e-05 | 235 | 211 | 9 | 30258100 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | ACACA USP11 MCM3 ZNF318 NKTR ASCC3 HECTD1 MIA3 TUT7 POLR2B HECTD4 AGPS | 1.78e-05 | 440 | 211 | 12 | 34244565 |
| Pubmed | 1.80e-05 | 9 | 211 | 3 | 33348080 | ||
| Pubmed | 2.07e-05 | 27 | 211 | 4 | 23471215 | ||
| Pubmed | 2.40e-05 | 28 | 211 | 4 | 20689807 | ||
| Pubmed | Lack of placental neurosteroid alters cortical development and female somatosensory function. | 2.56e-05 | 10 | 211 | 3 | 36313771 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | MYH10 MYH11 RTN4R CC2D1A AKR1C4 AKR1C1 PYGL HSP90AA2P HSP90AB3P GPLD1 PDCD6 ANXA3 HID1 ACTR1B SLC12A1 LRP2 AKR1C3 MMRN2 FTL | 3.19e-05 | 1070 | 211 | 19 | 23533145 |
| Pubmed | Role of acetylation and extracellular location of heat shock protein 90alpha in tumor cell invasion. | 3.66e-05 | 2 | 211 | 2 | 18559531 | |
| Pubmed | Loss of TSC2 confers resistance to ceramide and nutrient deprivation. | 3.66e-05 | 2 | 211 | 2 | 23604129 | |
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 21911744 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 27251940 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 24122895 | ||
| Pubmed | mTORC2 is required for proliferation and survival of TSC2-null cells. | 3.66e-05 | 2 | 211 | 2 | 21482669 | |
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 32081420 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 30367463 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 23699409 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 35154153 | ||
| Interaction | LRRC31 interactions | MYH10 MYH11 ACACA TRIO PLEC ASCC3 HECTD1 TUT7 MSH2 MTOR DOCK7 | 1.02e-05 | 205 | 209 | 11 | int:LRRC31 |
| Interaction | SIRT7 interactions | MYH10 ACACA NCKAP1 USP11 SPTAN1 ZNF318 KARS1 MDN1 PYGL PLEC ASCC3 HECTD1 ANKRD52 CLUH TUT7 MSH2 LMNB2 P4HB MTOR DOCK7 FTL PCNT | 1.04e-05 | 744 | 209 | 22 | int:SIRT7 |
| Interaction | YWHAH interactions | DLG5 MYH11 KCTD13 NCKAP1 MYO1E TRIO SPTAN1 PAK4 CCDC18 CC2D1A TSC2 BAP1 JUP NKTR PLEC HECTD1 MTMR12 HECTD4 RAB11FIP1 RFX7 ARRB1 CEP89 MTOR DOCK7 TMEM102 PRKCZ FGD6 PCNT | 1.07e-05 | 1102 | 209 | 28 | int:YWHAH |
| Interaction | EXOC1 interactions | 1.88e-05 | 143 | 209 | 9 | int:EXOC1 | |
| Interaction | AMOT interactions | DLG5 KCTD13 USP11 CCDC18 BAP1 HECTD1 ANKRD52 MIA3 NAGK LMNB2 TNKS EP300 PCNT | 2.42e-05 | 312 | 209 | 13 | int:AMOT |
| Interaction | NPHP4 interactions | MYH10 SPTAN1 JUP PYGL PLEC CPLANE1 CLUH POLR2B CEP164 CEP89 FTL | 3.76e-05 | 236 | 209 | 11 | int:NPHP4 |
| Interaction | YWHAQ interactions | DLG5 MYH11 ACACA KCTD13 NCKAP1 USP11 PAK4 CCDC18 MCM3 TSC2 BAP1 PLEC HECTD1 MTMR12 PDCD6 HECTD4 OBSL1 RAB11FIP1 RFX7 ARRB1 CEP89 P4HB MTOR DOCK7 TMEM102 PRKCZ FGD6 | 3.79e-05 | 1118 | 209 | 27 | int:YWHAQ |
| Interaction | YWHAG interactions | DLG5 MYH10 KCTD13 NCKAP1 SPTAN1 PAK4 CCDC18 MCM3 TSC2 BAP1 LPIN1 JUP MDN1 NKTR HECTD1 MTMR12 NGB HECTD4 RAB11FIP1 PPEF2 RFX7 ARRB1 CEP89 P4HB MTOR DOCK7 TMEM102 PRKCZ FGD6 | 3.85e-05 | 1248 | 209 | 29 | int:YWHAG |
| Interaction | YWHAZ interactions | DLG5 MYH10 MYH11 PNMA1 KCTD13 NCKAP1 SPTAN1 PAK4 CCDC18 TSC2 BAP1 JUP PLEC HECTD1 MTMR12 NGB HECTD4 OBSL1 RAB11FIP1 EXOC8 ARRB1 CEP89 MTOR CD28 DOCK7 TMEM102 PRKCZ FGD6 EP300 PCNT | 4.15e-05 | 1319 | 209 | 30 | int:YWHAZ |
| Interaction | YWHAE interactions | DLG5 MYH10 MYH11 KCTD13 NCKAP1 SPTAN1 PAK4 CCDC18 TSC2 TTC3 BAP1 LPIN1 JUP HECTD1 CACNB1 MTMR12 NGB OBSL1 CFAP43 RAB11FIP1 ARRB1 CEP89 MTOR CD28 STK33 DOCK7 TMEM102 ARHGAP45 FGD6 | 4.32e-05 | 1256 | 209 | 29 | int:YWHAE |
| Interaction | HSD17B7P2 interactions | 5.86e-05 | 21 | 209 | 4 | int:HSD17B7P2 | |
| Interaction | AKR1C4 interactions | 5.93e-05 | 8 | 209 | 3 | int:AKR1C4 | |
| Interaction | KRT8 interactions | DLG5 CCDC18 TTC3 BAP1 FAF2 PLEC HECTD1 ANKRD52 CLUH MIA3 OBSL1 PPEF2 CEP89 DOCK7 PCNT | 6.04e-05 | 441 | 209 | 15 | int:KRT8 |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | RASGRP4 PAK4 FXYD5 RTN2 ZNF776 SARS2 DHDH CLEC11A PPP1R37 LILRA5 ZSCAN5A LGI4 ZSCAN5B CEP89 FTL SBK3 | 1.42e-04 | 1192 | 211 | 16 | chr19q13 |
| Cytoband | 10p15-p14 | 3.12e-04 | 6 | 211 | 2 | 10p15-p14 | |
| GeneFamily | Myosin heavy chains | 1.89e-04 | 15 | 139 | 3 | 1098 | |
| GeneFamily | Aldo-keto reductases | 1.89e-04 | 15 | 139 | 3 | 399 | |
| GeneFamily | Phosphodiesterases | 8.00e-04 | 24 | 139 | 3 | 681 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 1.02e-03 | 26 | 139 | 3 | 904 | |
| Coexpression | GSE19401_UNSTIM_VS_PAM2CSK4_STIM_FOLLICULAR_DC_UP | INPP5K SNX13 KARS1 CSRNP2 ASCC3 PLK3 CACNB4 SBNO2 HSD17B6 PCNT | 4.61e-06 | 197 | 210 | 10 | M7670 |
| Coexpression | FLECHNER_BIOPSY_KIDNEY_TRANSPLANT_REJECTED_VS_OK_DN | ABCC4 MYH10 MYH11 NCKAP1 PDZK1 AKR1C1 HPGD FECH FGF9 SETD3 TSPYL4 CBR4 OXA1L LRP2 AKR1C3 SLC4A4 | 1.10e-05 | 553 | 210 | 16 | M1475 |
| Coexpression | GSE37301_CD4_TCELL_VS_RAG2_KO_NK_CELL_DN | 1.57e-05 | 180 | 210 | 9 | M8906 | |
| Coexpression | GOLDRATH_IMMUNE_MEMORY | 1.94e-05 | 69 | 210 | 6 | MM621 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | TSC2 ZNF318 TTC3 AKR1C1 RYR2 LPIN1 CYRIA MDN1 FGF9 VAV3 ST8SIA4 TSPYL4 CACNB4 MIA3 SYT6 RFX7 CELSR3 VWA5A SLITRK5 SV2C TNKS PRKCZ GOLGA8A | 2.97e-05 | 1106 | 210 | 23 | M39071 |
| Coexpression | GSE27241_CTRL_VS_DIGOXIN_TREATED_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_DN | 3.20e-05 | 197 | 210 | 9 | M8227 | |
| Coexpression | GSE14000_TRANSLATED_RNA_VS_MRNA_4H_LPS_DC_UP | 3.46e-05 | 199 | 210 | 9 | M3328 | |
| Coexpression | GSE23321_CENTRAL_VS_EFFECTOR_MEMORY_CD8_TCELL_UP | 3.60e-05 | 200 | 210 | 9 | M8433 | |
| Coexpression | GSE21380_NON_TFH_VS_TFH_CD4_TCELL_DN | 3.60e-05 | 200 | 210 | 9 | M7502 | |
| Coexpression | GSE2585_AIRE_KO_VS_WT_CD80_HIGH_MTEC_UP | 3.60e-05 | 200 | 210 | 9 | M6266 | |
| Coexpression | FIRESTEIN_PROLIFERATION | 6.07e-05 | 166 | 210 | 8 | M5354 | |
| Coexpression | HOFFMANN_PRE_BI_TO_LARGE_PRE_BII_LYMPHOCYTE_DN | 6.36e-05 | 85 | 210 | 6 | MM802 | |
| Coexpression | LEE_BMP2_TARGETS_UP | INHBB LIX1L AKR1C4 RTN2 AKR1C1 AK3 ADHFE1 HPGD VAV3 RAB13 NTRK2 SESN3 LRRK1 LRIG1 VWA5A AKR1C3 MMRN2 PKN1 | 9.24e-05 | 805 | 210 | 18 | MM1067 |
| Coexpression | GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_DN | 1.07e-04 | 180 | 210 | 8 | M6878 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | RASGRP4 KCTD13 SPTAN1 FXYD5 IRF7 KDM5D GRAMD4 LPIN1 ADHFE1 ACCS NKTR NAGK VASH1 RAB11FIP1 DENND3 OXA1L FTL EP300 PCNT | 1.34e-04 | 905 | 210 | 19 | M40865 |
| Coexpression | PUJANA_BREAST_CANCER_LIT_INT_NETWORK | 1.66e-04 | 101 | 210 | 6 | M15356 | |
| Coexpression | JOHNSTONE_PARVB_TARGETS_2_UP | 1.74e-04 | 145 | 210 | 7 | M2238 | |
| Coexpression | DESCARTES_ORGANOGENESIS_INTERMEDIATE_MESODERM | 1.93e-04 | 36 | 210 | 4 | MM3660 | |
| Coexpression | ERBB2_UP.V1_DN | 1.99e-04 | 197 | 210 | 8 | M2635 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_MONOCYTE_UP | 2.06e-04 | 198 | 210 | 8 | M4478 | |
| Coexpression | GSE13484_3H_UNSTIM_VS_YF17D_VACCINE_STIM_PBMC_UP | 2.13e-04 | 199 | 210 | 8 | M3266 | |
| Coexpression | GSE13485_DAY1_VS_DAY3_YF17D_VACCINE_PBMC_DN | 2.13e-04 | 199 | 210 | 8 | M3294 | |
| Coexpression | GSE360_T_GONDII_VS_B_MALAYI_LOW_DOSE_DC_DN | 2.13e-04 | 199 | 210 | 8 | M5219 | |
| Coexpression | GSE39820_TGFBETA3_IL6_VS_TGFBETA3_IL6_IL23A_TREATED_CD4_TCELL_UP | 2.13e-04 | 199 | 210 | 8 | M5620 | |
| Coexpression | HAHTOLA_CTCL_PATHOGENESIS | 2.15e-04 | 15 | 210 | 3 | M1416 | |
| Coexpression | GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_UP | 2.20e-04 | 200 | 210 | 8 | M9499 | |
| Coexpression | GSE41867_DAY8_VS_DAY15_LCMV_CLONE13_EFFECTOR_CD8_TCELL_UP | 2.20e-04 | 200 | 210 | 8 | M9449 | |
| Coexpression | GSE14308_NAIVE_CD4_TCELL_VS_NATURAL_TREG_DN | 2.20e-04 | 200 | 210 | 8 | M3394 | |
| Coexpression | GSE18281_PERIMEDULLARY_CORTICAL_REGION_VS_WHOLE_CORTEX_THYMUS_UP | 2.20e-04 | 200 | 210 | 8 | M7256 | |
| Coexpression | GSE22935_UNSTIM_VS_24H_MBOVIS_BCG_STIM_MYD88_KO_MACROPHAGE_DN | 2.20e-04 | 200 | 210 | 8 | M7771 | |
| Coexpression | GSE37532_WT_VS_PPARG_KO_LN_TCONV_UP | 2.20e-04 | 200 | 210 | 8 | M8954 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL10_STIM_IL6_KO_MACROPHAGE_180MIN_UP | 2.20e-04 | 200 | 210 | 8 | M6623 | |
| Coexpression | GSE360_HIGH_VS_LOW_DOSE_B_MALAYI_DC_DN | 2.20e-04 | 200 | 210 | 8 | M5225 | |
| Coexpression | GSE3982_DC_VS_TH2_UP | 2.20e-04 | 200 | 210 | 8 | M5484 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#3_top-relative-expression-ranked_200 | 1.29e-05 | 54 | 204 | 6 | gudmap_developingKidney_e15.5_cortic collect duct_200_k3 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.26e-08 | 160 | 210 | 9 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.26e-08 | 160 | 210 | 9 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.25e-07 | 197 | 210 | 9 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | COVID-19-COVID-19_Severe-Others-HSPC|COVID-19_Severe / Disease, condition lineage and cell class | 4.62e-07 | 199 | 210 | 9 | 25de67b6c9c8d6bb9a538e071a40ef865906c95d | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.17e-07 | 154 | 210 | 8 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.17e-07 | 154 | 210 | 8 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-plasmacytoid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-06 | 167 | 210 | 8 | b25646b6653cd8814dbeae4c74ce899ede105200 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Plasmacytoid_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-06 | 167 | 210 | 8 | e0f2509e86302eca8352821bce12597f6c51fc24 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.41e-06 | 181 | 210 | 8 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | severe-unassigned|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.56e-06 | 128 | 210 | 7 | bef9cf0078fa8498d63f0723f1fa4a3c92405e10 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-06 | 184 | 210 | 8 | 6b0c110d8930df99043c3b99cf4d873985126960 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.73e-06 | 184 | 210 | 8 | 35928fc5f7bbf8c7b09181a2bd27e22dff42ec16 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.95e-06 | 186 | 210 | 8 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.33e-06 | 189 | 210 | 8 | b8cbfc47f3f40b6fccd15899d58c87d07b0001aa | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.88e-06 | 193 | 210 | 8 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.03e-06 | 194 | 210 | 8 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.52e-06 | 197 | 210 | 8 | bd7e18a0fed085cfb8ed0e478d1f172a173febbe | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.52e-06 | 197 | 210 | 8 | 7e06aee2add54eeff4a9927d9b04b5797160113b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Astrocyte|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.52e-06 | 197 | 210 | 8 | 5bcf963f21d23edafef1e90dc1de24cd3b0fccce | |
| ToppCell | PSB-critical-LOC-Epithelial-Basal|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.87e-06 | 199 | 210 | 8 | 2add64c3e4cb6384ec381f34c3f1f77e13e3f27c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.05e-06 | 200 | 210 | 8 | 74ceebee9af63f8b3ec5857eff1b662752bc3862 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.05e-06 | 200 | 210 | 8 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.05e-06 | 200 | 210 | 8 | 881ab995c90d75fd987d6e8f1f926a4bfcc4235f | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 5.05e-06 | 200 | 210 | 8 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 5.05e-06 | 200 | 210 | 8 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.05e-06 | 155 | 210 | 7 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.05e-06 | 155 | 210 | 7 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | LPS_only-Myeloid-Monocytes,_Macrophages-T-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-05 | 158 | 210 | 7 | 91d8c93af328c3bbebe1d8f019b94849ebc548c0 | |
| ToppCell | droplet-Fat-Gat|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 164 | 210 | 7 | c7ad946829c655038b33748dddd7d68c15489034 | |
| ToppCell | droplet-Fat-Gat-18m|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-05 | 164 | 210 | 7 | 3aae702a23fbf1d36a6f18596c23e985581de815 | |
| ToppCell | facs-Limb_Muscle-forelimb_and_hindlimb-18m-Lymphocytic-T_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-05 | 168 | 210 | 7 | 182f08106ac65ea501e2fb9139d3b44b7c4662c9 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-05 | 168 | 210 | 7 | f45dbcd7753117a3e41e1412bce2100d52fa7fd0 | |
| ToppCell | facs-SCAT-Fat-18m-Lymphocytic-T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-05 | 169 | 210 | 7 | 700a3a36c379872585204caa6a6cc269b036ae22 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.59e-05 | 169 | 210 | 7 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.59e-05 | 169 | 210 | 7 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-05 | 169 | 210 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-05 | 173 | 210 | 7 | 12f779b8dce79431b2d1002ba524dd3f9566aeb0 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_4|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.92e-05 | 174 | 210 | 7 | 110369f6b78de34a6d934b5b47cecd023347bc80 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.99e-05 | 175 | 210 | 7 | dbd9dac129fb6ae5f55e7b96d04b37585458dc4a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Monocytic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.06e-05 | 176 | 210 | 7 | 926ed37e636fe4dd3a18731cea15761f0c2c285a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-club_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.06e-05 | 176 | 210 | 7 | 3bbac5c2397535631fce8fa98f6ddb4fe0260351 | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-05 | 177 | 210 | 7 | 26bad614560609d318bfc9c235a698bca4e1c22c | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-Ependyma|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-05 | 177 | 210 | 7 | ae01c19403a09f7ba5e4beafdfcd1b8eebdadcb7 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Mesenchymal-ependymal_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-05 | 177 | 210 | 7 | bd3d07bdef6e903995d4bbfb6ff3a5e1d9fb70cc | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.22e-05 | 178 | 210 | 7 | f5ed4a6e3eb8056b1be1fb311021710c95bdf888 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Mucinous_Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.30e-05 | 179 | 210 | 7 | cc079ba015326dccde955c5eafa3e4a2e40de192 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Myofibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-05 | 180 | 210 | 7 | d67d3196e6cc3dcd31023a4dc69310226181d583 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-pulmonary_interstitial_fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-05 | 180 | 210 | 7 | 573308d43425d9fba20787abdb7f8efefc48efb5 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.47e-05 | 181 | 210 | 7 | 090e89b506d945e123e647d08947e9649a65ce7c | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-05 | 184 | 210 | 7 | 264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-05 | 184 | 210 | 7 | d7eccbd21c480d907fdc8eff2bf5ae22ae452221 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-05 | 184 | 210 | 7 | 22010cfe0428ebfa40952cc1a1a12ad3d25b35c9 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 2.84e-05 | 185 | 210 | 7 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.84e-05 | 185 | 210 | 7 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.84e-05 | 185 | 210 | 7 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.94e-05 | 186 | 210 | 7 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.94e-05 | 186 | 210 | 7 | 85787ff207f109ec7e3c0f729ba9bda739c2fdc9 | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | 3.04e-05 | 187 | 210 | 7 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf | |
| ToppCell | normal_Lung-Myeloid_cells-pDCs|normal_Lung / Location, Cell class and cell subclass | 3.04e-05 | 187 | 210 | 7 | d36751372fd40a46441f07735c9c3c5dcb503f24 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.15e-05 | 188 | 210 | 7 | 59d5c7b147af118442adadf708ce2d1422b1e9aa | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Non-classical_Monocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.15e-05 | 188 | 210 | 7 | 4e27ada1bda88811b73376c8a6136cbfc83bfdb9 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_granulocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.15e-05 | 188 | 210 | 7 | 36ff615154d6d9e3ba6ccb73a0f11574bcbf5ece | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_macrophage|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.15e-05 | 188 | 210 | 7 | 2e268d8091e25d50bf05f26517d3ceb583801fd4 | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Endothelial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-05 | 189 | 210 | 7 | 16a4c92dd7a0d60f3691bd3130a091a9a54730f1 | |
| ToppCell | Fetal_29-31_weeks-Immune-monocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.37e-05 | 190 | 210 | 7 | ad297172a74a80ed5c10f921e15efd1da0fd2d6b | |
| ToppCell | Adult-Immune-monocyte-D175|Adult / Lineage, Cell type, age group and donor | 3.48e-05 | 191 | 210 | 7 | cbebb4d9550fdcd606cb3685ac9546c6b73fd422 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_immature-endo_immature_arterial2_(6)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.48e-05 | 191 | 210 | 7 | e3fc5c92491b6e334abffbf085c00a0b5fa1aed2 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.48e-05 | 191 | 210 | 7 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.48e-05 | 191 | 210 | 7 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.48e-05 | 191 | 210 | 7 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | Control-Treg|Control / Disease group and Cell class | 3.60e-05 | 192 | 210 | 7 | 3a9a8ac2aa278adde848608f9bb92a002dbb9bcc | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 3.60e-05 | 192 | 210 | 7 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs_st-18m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.60e-05 | 192 | 210 | 7 | 6806a1a9fe00395dc1abc3e0124b4261dc701f31 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.60e-05 | 192 | 210 | 7 | ee27d27e3d269764dbe8711d0b37ff9331a298a9 | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 3.60e-05 | 192 | 210 | 7 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-naive_regulatory_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.72e-05 | 193 | 210 | 7 | 28138c35ea82c6b2163f0cae045ca55859347c73 | |
| ToppCell | Nasal_Brush-Immune|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.84e-05 | 194 | 210 | 7 | 3135bc4a8112c5dee108e3b8e775f508b65191f1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-05 | 194 | 210 | 7 | 46070fbb0ee0eb9e1801c43b73a15707471056dc | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.84e-05 | 194 | 210 | 7 | abacb6a8d7a9003f2f6c2be0305507f1c1c50347 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.97e-05 | 195 | 210 | 7 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_mature|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.97e-05 | 195 | 210 | 7 | 31353269591c9eee84872838e91995d4a035da46 | |
| ToppCell | 11.5-Distal-Endothelial|Distal / Age, Tissue, Lineage and Cell class | 3.97e-05 | 195 | 210 | 7 | efdede0f476883ffddd247fa7bc6449e7932613e | |
| ToppCell | 11.5-Distal-Endothelial-Endothelial|Distal / Age, Tissue, Lineage and Cell class | 3.97e-05 | 195 | 210 | 7 | 1e9b52b201ab6c78f536609e2afe1d680c71a6e7 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Stem_cells-retina_progenitors|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 3.97e-05 | 195 | 210 | 7 | 06a437459717dc3c41ec343b1ec57cf910ecbdd8 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.97e-05 | 195 | 210 | 7 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.10e-05 | 196 | 210 | 7 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.10e-05 | 196 | 210 | 7 | e02301642243df483fd066d978317c113c04692b | |
| ToppCell | NS-control-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.10e-05 | 196 | 210 | 7 | d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a | |
| ToppCell | severe-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.24e-05 | 197 | 210 | 7 | 70704b149b2820b8601d2495b7cd9cbe91eda262 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.24e-05 | 197 | 210 | 7 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | NS-control-d_0-4-Myeloid-Non-resident_Macrophage|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.24e-05 | 197 | 210 | 7 | 496a1115071a1be6928786192de49f3adf197dfb | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.24e-05 | 197 | 210 | 7 | 10190b877bf46ba2163d203df9dd3b498c66e52f | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.24e-05 | 197 | 210 | 7 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.24e-05 | 197 | 210 | 7 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_cycling-endo_proliferating3_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.24e-05 | 197 | 210 | 7 | aedc1e3ed6b558bf2f7649919f43049f8348ab85 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.0.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.37e-05 | 198 | 210 | 7 | d5c816fb894f55acbbab188e6262668acc422fb9 | |
| ToppCell | erythropoietic-Basophilic_Erythroblast|World / Lineage and Cell class | 4.37e-05 | 198 | 210 | 7 | b3db4db02c0e659163cefb3d83f53e4940cc04bf | |
| ToppCell | PCW_13-14-Endothelial-Endothelial_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.37e-05 | 198 | 210 | 7 | 8fb624407abb9cb711d8d8a8665014cf6e39559a | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.37e-05 | 198 | 210 | 7 | eac26ed95b4a4343a5dfe1fbecef9374e5947884 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.37e-05 | 198 | 210 | 7 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| Drug | 1-acenaphthenol | 1.16e-07 | 14 | 209 | 5 | CID000022750 | |
| Drug | papaverine | PDE6A PDE6B INPP5K RYR2 VPS51 GPLD1 CACNB1 CACNB4 NGB ANXA3 PDE8B | 7.31e-07 | 176 | 209 | 11 | CID000004680 |
| Drug | 2,3-hexanedione | 1.39e-06 | 10 | 209 | 4 | CID000019707 | |
| Drug | benzene dihydrodiol | 1.44e-06 | 22 | 209 | 5 | CID000000418 | |
| Drug | chlordecone alcohol | 2.16e-06 | 11 | 209 | 4 | CID000013946 | |
| Drug | cloxazolam | 3.03e-06 | 4 | 209 | 3 | ctd:C005522 | |
| Drug | Pregnanes | 3.03e-06 | 4 | 209 | 3 | ctd:D011278 | |
| Drug | tetralol | 3.03e-06 | 4 | 209 | 3 | ctd:C019106 | |
| Drug | 3',3'',5',5''-tetrabromophenolphthalein | 3.03e-06 | 4 | 209 | 3 | ctd:C018156 | |
| Drug | DBD-H | 3.03e-06 | 4 | 209 | 3 | CID000131382 | |
| Drug | DMBA-3,4-dihydrodiol | 4.62e-06 | 13 | 209 | 4 | CID000050096 | |
| Drug | 1-indanol | 4.62e-06 | 13 | 209 | 4 | CID000022819 | |
| Drug | p-nitrobenzaldehyde | 4.96e-06 | 48 | 209 | 6 | CID000000541 | |
| Drug | D-myo-inositol-1,4,5-triphosphate | MYO1E INPP5K RYR2 PYGL GNA12 MOK GPLD1 CACNB1 CACNB4 ACTRT2 AGPS ACTR1B ARRB1 MTOR CD28 PRKCZ SLC4A4 MAPK13 | 5.55e-06 | 568 | 209 | 18 | CID000000806 |
| Drug | LY294002 | MYH10 MYH11 PAK4 ETV6 TSC2 JAK3 RPS6KA6 HSP90AA2P MOK GPLD1 NGB NTRK2 ACTRT2 ACTR1B MTOR CD28 PKN1 TNKS PRKCZ MAPK13 EP300 | 5.91e-06 | 748 | 209 | 21 | CID000003973 |
| Drug | guanosine 3',5'-cyclic monophosphoric acid | ABCC4 PDE6A PDE6B INHBB RYR2 SCML2 RAB13 HSP90AA2P CACNB1 CACNB4 NGB POLR2B ACTRT2 ACTR1B ARRB1 PDE8B PRKCZ MAPK13 | 6.89e-06 | 577 | 209 | 18 | CID000000295 |
| Drug | Hydroxysteroids | 7.52e-06 | 5 | 209 | 3 | ctd:D006914 | |
| Drug | cresolphthalein | 7.52e-06 | 5 | 209 | 3 | ctd:C010092 | |
| Drug | 5 alpha-dihydrotestosterone | ABCC4 ACACA INHBB PAK4 ZNF318 AKR1C4 AKR1C1 ADHFE1 DHDH AGPS HSD17B6 AKR1C3 EP300 | 9.81e-06 | 323 | 209 | 13 | CID000000015 |
| Drug | Dantrolene sodium salt [14663-23-1]; Down 200; 11.8uM; PC3; HT_HG-U133A | TRIO KDM5C SVEP1 NTRK2 LRRK1 CEP164 VWA5A PDE8B SLITRK5 MMRN2 | 1.24e-05 | 193 | 209 | 10 | 4343_DN |
| Drug | Guaifenesin [93-14-1]; Up 200; 20.2uM; PC3; HT_HG-U133A | PDE6B ETV6 SVEP1 MINDY3 CLEC11A PICK1 LIG4 HSD17B6 LRP2 SLC4A4 | 1.36e-05 | 195 | 209 | 10 | 4549_UP |
| Drug | Epicatechin-(-) [154-23-4]; Down 200; 13.8uM; HL60; HT_HG-U133A | RYR2 MINDY3 PLK3 CACNB1 LRRK1 CELSR3 HSD17B6 SLITRK5 MAPK13 CDH10 | 1.42e-05 | 196 | 209 | 10 | 2160_DN |
| Drug | haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A_EA | ABCC4 NCKAP1 KDM5C SIDT1 LPIN1 MINDY3 NAA35 RAD54L CELSR3 MTOR | 1.42e-05 | 196 | 209 | 10 | 1082_UP |
| Drug | Tiapride hydrochloride [51012-33-0]; Up 200; 11uM; HL60; HT_HG-U133A | INPP5K ETV6 SNX13 NKTR PLK3 LRRK1 VWA5A HSD17B6 SLITRK5 LRP2 | 1.42e-05 | 196 | 209 | 10 | 2331_UP |
| Drug | AC1L93E5 | 1.49e-05 | 6 | 209 | 3 | CID000412383 | |
| Drug | Medazepam | 1.49e-05 | 6 | 209 | 3 | ctd:D008472 | |
| Drug | NSC36919 | 1.51e-05 | 58 | 209 | 6 | CID000235496 | |
| Drug | Serotonin hydrochloride [153-98-0]; Down 200; 18.8uM; MCF7; HT_HG-U133A | TRIO SIDT1 IRF7 RYR2 CLEC11A PARPBP CEP164 SBNO2 LRIG1 HSD17B6 | 1.55e-05 | 198 | 209 | 10 | 3311_DN |
| Drug | Scopoletin [92-61-5]; Down 200; 20.8uM; HL60; HT_HG-U133A | SPTAN1 RTN2 CLEC11A PLEC PLK3 CACNB1 MTMR12 CEP164 VWA5A PKN1 | 1.55e-05 | 198 | 209 | 10 | 3131_DN |
| Drug | Naphazoline hydrochloride [550-99-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A | TRIO SVEP1 SNX13 PPP1R37 PLK3 CACNB1 POU1F1 MYH15 SLC4A4 CDH10 | 1.55e-05 | 198 | 209 | 10 | 1466_UP |
| Drug | Merbromin [129-16-8]; Down 200; 5uM; HL60; HT_HG-U133A | MYO1E TRIO SPTAN1 RYR2 JAK3 CACNB1 MTMR12 SBNO2 MYH15 MAPK13 | 1.62e-05 | 199 | 209 | 10 | 2577_DN |
| Drug | nicotinaldehyde | 1.91e-05 | 18 | 209 | 4 | CID000010371 | |
| Drug | wartmannin | MYH10 MYH11 MYO1E TSC2 STAB1 JAK3 RPS6KA6 PLK3 HSP90AA2P MOK GPLD1 NTRK2 ACTRT2 ACTR1B LIG4 MTOR CD28 PKN1 PRKCZ MAPK13 EP300 | 1.99e-05 | 811 | 209 | 21 | CID000005691 |
| Drug | 9,10-phenanthrenequinone | 2.03e-05 | 61 | 209 | 6 | CID000006763 | |
| Drug | AC1L8ZBW | 2.40e-05 | 19 | 209 | 4 | CID000435356 | |
| Drug | 20 alpha-dihydroprogesterone | 3.15e-05 | 40 | 209 | 5 | CID000008956 | |
| Drug | eye gene | MYH10 MYH11 ACACA MYO1E TSC2 PYGL GPLD1 ACTRT2 ACTR1B MTOR PRKCZ MAPK13 EP300 | 3.95e-05 | 369 | 209 | 13 | CID000004782 |
| Drug | diclofop | 4.13e-05 | 8 | 209 | 3 | CID000038687 | |
| Drug | Nitrazepam | 4.13e-05 | 8 | 209 | 3 | ctd:D009567 | |
| Drug | ethacrynic acid | 4.22e-05 | 138 | 209 | 8 | CID000003278 | |
| Drug | manganese | RYR2 KARS1 FECH RPS6KA6 PYGL POLN ST8SIA4 CACNB1 CACNB4 NAGK UBD NGB POLR2B ACTRT2 GBA3 ACTR1B LIG4 MTOR FTL PKN1 | 4.41e-05 | 791 | 209 | 20 | CID000023930 |
| Drug | beryllium fluoride | 4.67e-05 | 103 | 209 | 7 | CID000024589 | |
| Drug | 1-hydroxymethylpyrene | 5.33e-05 | 23 | 209 | 4 | CID000104977 | |
| Drug | 2-carboxybenzaldehyde | 5.33e-05 | 23 | 209 | 4 | CID000008406 | |
| Drug | 4-hydroxybenzoic acid | 6.15e-05 | 9 | 209 | 3 | ctd:C038193 | |
| Drug | 20-alpha-Dihydroprogesterone | 6.15e-05 | 9 | 209 | 3 | ctd:D004092 | |
| Drug | 4-oxo-2-nonenal | 6.15e-05 | 9 | 209 | 3 | ctd:C403894 | |
| Drug | medazepam | 6.35e-05 | 24 | 209 | 4 | CID000004041 | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; HL60; HT_HG-U133A | 8.01e-05 | 194 | 209 | 9 | 6173_UP | |
| Drug | Pempidine tartrate [546-48-5]; Up 200; 13uM; HL60; HT_HG-U133A | 8.33e-05 | 195 | 209 | 9 | 2172_UP | |
| Drug | alpha-methylcinnamic acid | 8.39e-05 | 2 | 209 | 2 | ctd:C510582 | |
| Drug | 2-nitroethanol | 8.39e-05 | 2 | 209 | 2 | CID000012252 | |
| Drug | terbacil | 8.39e-05 | 2 | 209 | 2 | CID000022188 | |
| Drug | magnesium | MYH11 MYO1E PAK4 OXCT2 RYR2 LPIN1 NT5C1A ADHFE1 KARS1 PLEC POLN ST8SIA4 HSP90AA2P GPLD1 NAGK POLR2B ACTRT2 MSH2 EXOC8 GBA3 ACTR1B LIG4 SLC12A1 PKN1 PRKCZ MAPK13 DNAH11 | 8.63e-05 | 1325 | 209 | 27 | CID000000888 |
| Drug | Dyclonine hydrochloride [536-43-6]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 8.67e-05 | 196 | 209 | 9 | 7423_UP | |
| Drug | Cefsulodin sodium salt [52152-93-9]; Up 200; 7.2uM; HL60; HT_HG-U133A | 8.67e-05 | 196 | 209 | 9 | 2988_UP | |
| Drug | ICI182,780; Down 200; 1uM; PC3; HT_HG-U133A | 8.67e-05 | 196 | 209 | 9 | 7495_DN | |
| Drug | Moricizine hydrochloride [31883-05-3]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 8.67e-05 | 196 | 209 | 9 | 6000_UP | |
| Drug | octyl gallate | 8.73e-05 | 10 | 209 | 3 | ctd:C016627 | |
| Drug | S 10 | 8.80e-05 | 26 | 209 | 4 | CID000021594 | |
| Drug | T694 | 8.91e-05 | 114 | 209 | 7 | CID000000872 | |
| Drug | Alfadolone acetate [23930-37-2]; Down 200; 10.2uM; HL60; HT_HG-U133A | 9.01e-05 | 197 | 209 | 9 | 3127_DN | |
| Drug | Menadione [58-27-5]; Down 200; 23.2uM; HL60; HT_HG-U133A | 9.01e-05 | 197 | 209 | 9 | 2439_DN | |
| Drug | NSC9700 | MYH10 MYH11 INHBB AKR1C4 KDM5D AKR1C1 JAK3 ADHFE1 DHDH PARPBP MOK PDCD6 GAL HSD17B6 AKR1C3 MAPK13 | 9.34e-05 | 578 | 209 | 16 | CID000005408 |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | 9.37e-05 | 198 | 209 | 9 | 7003_DN | |
| Drug | Roxarsone [121-19-7]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 9.37e-05 | 198 | 209 | 9 | 5470_DN | |
| Drug | Merbromin [129-16-8]; Up 200; 5uM; MCF7; HT_HG-U133A | 9.37e-05 | 198 | 209 | 9 | 3439_UP | |
| Drug | hydroxybutyrate | 9.42e-05 | 115 | 209 | 7 | CID000010413 | |
| Drug | AMP group | ABCC4 PDE6A ACACA ETFDH AK3 NT5C1A ADHFE1 KARS1 SARS2 PYGL ASCC3 ST8SIA4 LIG4 MTOR PKN1 PRKCZ | 9.53e-05 | 579 | 209 | 16 | CID000000224 |
| Drug | blebbistatin | 9.94e-05 | 116 | 209 | 7 | CID003476986 | |
| Drug | Isoxsuprine hydrochloride [579-56-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.01e-04 | 200 | 209 | 9 | 4789_DN | |
| Drug | androstane-3,17-dione | 1.04e-04 | 51 | 209 | 5 | CID000000443 | |
| Drug | NSC611747 | MYH10 MYH11 MYO1E INPP5K RPS6KA6 PYGL ACTRT2 ACTR1B SLC12A1 MTOR PKN1 MAPK13 | 1.07e-04 | 352 | 209 | 12 | CID000002534 |
| Drug | phenylhydrazine | 1.09e-04 | 82 | 209 | 6 | CID000007516 | |
| Drug | oxalate | 1.09e-04 | 158 | 209 | 8 | CID000000971 | |
| Drug | AC1L9HHR | GIMAP4 MYO1E SPTAN1 OXCT2 GPLD1 ANXA3 POLR2B LMNB2 GBA3 PKN1 TNKS PRKCZ | 1.13e-04 | 354 | 209 | 12 | CID000445141 |
| Drug | Dihydroxydihydrobenzopyrenes | 1.19e-04 | 11 | 209 | 3 | ctd:D004101 | |
| Drug | NSC 60462 | 1.19e-04 | 11 | 209 | 3 | CID000097943 | |
| Drug | androstan-3-ol | 1.19e-04 | 160 | 209 | 8 | CID000092877 | |
| Drug | pentachlorophenol | 1.23e-04 | 120 | 209 | 7 | CID000000992 | |
| Drug | AC1L1IZ2 | MYH10 MYH11 MYO1E RYR2 RPS6KA6 HSP90AA2P NAGK ACTRT2 AGPS ACTR1B ARRB1 | 1.23e-04 | 304 | 209 | 11 | CID000004795 |
| Drug | tamibarotene | MYH10 MYH11 TRIO IRF7 TTC3 JAK3 LPIN1 MDN1 HPGD VAV3 TSPYL4 NTRK2 AGPS PKN1 ARHGAP45 GOLGA8A | 1.33e-04 | 596 | 209 | 16 | ctd:C061133 |
| Drug | formamide | 1.33e-04 | 85 | 209 | 6 | CID000000713 | |
| Drug | GW9662 | 1.36e-04 | 163 | 209 | 8 | CID000644213 | |
| Drug | nocodazole | MYH10 MYH11 GABARAP TSC2 GRAMD4 PLK3 MOCOS HSP90AA2P ACTRT2 LMNB2 ACTR1B MTOR PRKCZ PCNT | 1.41e-04 | 477 | 209 | 14 | CID000004122 |
| Drug | Phenolphthalein | 1.58e-04 | 12 | 209 | 3 | ctd:D020113 | |
| Drug | benzo(a)pyrene 7,8-dihydrodiol | 1.79e-04 | 31 | 209 | 4 | ctd:C017228 | |
| Drug | beta-NADP | ACACA AKR1C4 AKR1C1 ADHFE1 SARS2 DHDH HPGD PYGL HSP90AA2P ANXA3 AGPS CBR4 HSD17B6 AKR1C3 | 1.86e-04 | 490 | 209 | 14 | CID000000929 |
| Drug | methyl methanethiosulfonate | 1.92e-04 | 58 | 209 | 5 | CID000018064 | |
| Drug | serotonin | INPP5K CC2D1A ADHFE1 RPS6KA6 GNA12 MOK GPLD1 CACNB4 POLR2B ACTRT2 ACTR1B GAL P4HB PRKCZ MAPK13 | 1.97e-04 | 554 | 209 | 15 | CID000005202 |
| Drug | 4-formyl-benzoate | 2.04e-04 | 13 | 209 | 3 | CID000012088 | |
| Drug | flunisolide | 2.04e-04 | 13 | 209 | 3 | ctd:C007734 | |
| Drug | tripyridyltriazine | 2.04e-04 | 13 | 209 | 3 | CID000077258 | |
| Drug | ethylnylestradiol | ACACA INHBB IRF7 TSC2 AKR1C1 JAK3 HPGD PARPBP ZNF433 MOCOS HSP90AA2P MOK NGB POLR2B POU1F1 ACTRT2 MSH2 ACTR1B GAL HSD17B6 LRP2 AKR1C3 PRKCZ MAPK13 EP300 | 2.16e-04 | 1251 | 209 | 25 | CID000003285 |
| Drug | carbachol | MYH10 MYH11 INPP5K RYR2 RPS6KA6 ST8SIA4 MOK GPLD1 CACNB1 CACNB4 ACTRT2 ACTR1B GAL P4HB PRKCZ SLC4A4 MAPK13 | 2.19e-04 | 688 | 209 | 17 | CID000002551 |
| Drug | glutamate | GABRG3 INPP5K OXCT2 RYR2 KARS1 MDN1 PLEC PICK1 GPLD1 CACNB1 CACNB4 NTRK2 ACTRT2 GBA3 ACTR1B GAL LIG4 MTOR PRKCZ SLC4A4 MAPK13 | 2.22e-04 | 962 | 209 | 21 | CID000000611 |
| Drug | picolinic acid | 2.25e-04 | 60 | 209 | 5 | CID000001018 | |
| Drug | n-hexane | 2.29e-04 | 33 | 209 | 4 | ctd:C026385 | |
| Drug | DCNP | 2.29e-04 | 33 | 209 | 4 | CID000012066 | |
| Drug | caffeine | PDE6A PDE6B RYR2 NT5C1A ACCS PYGL GPLD1 CACNB1 CACNB4 PDCD6 ANXA3 GBA3 OXA1L PDE8B MAPK13 | 2.29e-04 | 562 | 209 | 15 | CID000002519 |
| Disease | Prostatic Neoplasms | ABCC4 PDZK1 BAP1 JUP FAF2 DHDH HPGD VAV3 NAGK ANXA3 SESN3 P4HB LRP2 AKR1C3 PRKCZ | 2.96e-05 | 616 | 205 | 15 | C0033578 |
| Disease | Malignant neoplasm of prostate | ABCC4 PDZK1 BAP1 JUP FAF2 DHDH HPGD VAV3 NAGK ANXA3 SESN3 P4HB LRP2 AKR1C3 PRKCZ | 2.96e-05 | 616 | 205 | 15 | C0376358 |
| Disease | Colorectal Carcinoma | ABCC4 ACACA ETFDH LPIN1 TTLL10 ST8SIA4 CACNB1 ZSCAN5A MSH2 LMNB2 LRP2 MMRN2 TNS4 PRKCZ EP300 | 1.27e-04 | 702 | 205 | 15 | C0009402 |
| Disease | Heredodegenerative Disorders, Nervous System | 1.43e-04 | 3 | 205 | 2 | C0751870 | |
| Disease | Neoplasms, Hormone-Dependent | 1.43e-04 | 3 | 205 | 2 | C0027661 | |
| Disease | Focal Cortical Dysplasia of Taylor, Type IIb | 1.43e-04 | 3 | 205 | 2 | C1846389 | |
| Disease | FOCAL CORTICAL DYSPLASIA OF TAYLOR | 1.43e-04 | 3 | 205 | 2 | C1846385 | |
| Disease | Focal Cortical Dysplasia of Taylor, Type IIa | 1.43e-04 | 3 | 205 | 2 | C1846386 | |
| Disease | Isolated focal cortical dysplasia type II | 1.43e-04 | 3 | 205 | 2 | cv:C1846385 | |
| Disease | FOCAL CORTICAL DYSPLASIA, TYPE II | 1.43e-04 | 3 | 205 | 2 | 607341 | |
| Disease | syndromic intellectual disability (implicated_via_orthology) | 1.73e-04 | 16 | 205 | 3 | DOID:0050888 (implicated_via_orthology) | |
| Disease | Tachycardia | 2.50e-04 | 18 | 205 | 3 | C0039231 | |
| Disease | Tachyarrhythmia | 2.50e-04 | 18 | 205 | 3 | C0080203 | |
| Disease | syndromic X-linked intellectual disability Claes-Jensen type (implicated_via_orthology) | 2.86e-04 | 4 | 205 | 2 | DOID:0060809 (implicated_via_orthology) | |
| Disease | Chronic myeloproliferative disorder | 2.95e-04 | 19 | 205 | 3 | C1292778 | |
| Disease | N-methylpipecolate measurement | 4.74e-04 | 5 | 205 | 2 | EFO_0800988 | |
| Disease | Hermaphroditism | 4.74e-04 | 5 | 205 | 2 | C0019269 | |
| Disease | Ambiguous Genitalia | 4.74e-04 | 5 | 205 | 2 | C0266362 | |
| Disease | Pseudohermaphroditism | 4.74e-04 | 5 | 205 | 2 | C0033804 | |
| Disease | Intersex Conditions | 4.74e-04 | 5 | 205 | 2 | C2930618 | |
| Disease | Sex Differentiation Disorders | 4.74e-04 | 5 | 205 | 2 | C2930619 | |
| Disease | Antihypertensive use measurement | 5.61e-04 | 265 | 205 | 8 | EFO_0009927 | |
| Disease | Ischemic stroke, fibrinogen measurement | 5.85e-04 | 55 | 205 | 4 | EFO_0004623, HP_0002140 | |
| Disease | leukemia | 5.85e-04 | 55 | 205 | 4 | C0023418 | |
| Disease | West Syndrome | 6.01e-04 | 24 | 205 | 3 | C0037769 | |
| Disease | aspartate aminotransferase measurement | DLG5 ETFDH SNX13 LPIN1 FECH FGF9 MOCOS UBD NTRK2 HECTD4 GBA3 MTOR STK33 TNKS SLC4A4 ARHGAP45 | 6.18e-04 | 904 | 205 | 16 | EFO_0004736 |
| Disease | X-12112 measurement | 7.07e-04 | 6 | 205 | 2 | EFO_0800705 | |
| Disease | fibrinogen measurement, factor VII measurement | 7.16e-04 | 58 | 205 | 4 | EFO_0004619, EFO_0004623 | |
| Disease | mean platelet volume | MYH11 MYO1E INPP5K SIDT1 FXYD5 MCM3 SVEP1 SNX13 CYRIA TTC13 PLEC PICK1 PCDHGA11 DOCK7 STYXL1 SV2C ARHGAP45 | 8.18e-04 | 1020 | 205 | 17 | EFO_0004584 |
| Disease | Precursor Cell Lymphoblastic Leukemia Lymphoma | 8.66e-04 | 61 | 205 | 4 | C1961102 | |
| Disease | stem cell growth factor-alpha measurement | 9.86e-04 | 7 | 205 | 2 | EFO_0020754 | |
| Disease | Disorders of Sex Development | 9.86e-04 | 7 | 205 | 2 | C0036875 | |
| Disease | atrioventricular septal defect (implicated_via_orthology) | 9.86e-04 | 7 | 205 | 2 | DOID:0050651 (implicated_via_orthology) | |
| Disease | Malignant mesothelioma | 1.00e-03 | 109 | 205 | 5 | C0345967 | |
| Disease | Ciliopathies | 1.05e-03 | 110 | 205 | 5 | C4277690 | |
| Disease | Child Development Disorders, Specific | 1.06e-03 | 29 | 205 | 3 | C0085997 | |
| Disease | Child Development Deviations | 1.06e-03 | 29 | 205 | 3 | C0085996 | |
| Disease | Liver Cirrhosis, Experimental | SPTAN1 FXYD5 AKR1C1 MINDY3 CYRIA ADHFE1 NAGK UBD ANXA3 ATP10D HSD17B6 DOCK7 AKR1C3 SLC4A4 | 1.10e-03 | 774 | 205 | 14 | C0023893 |
| Disease | Developmental Disabilities | 1.17e-03 | 30 | 205 | 3 | C0008073 | |
| Disease | anxiety disorder | 1.17e-03 | 30 | 205 | 3 | EFO_0006788 | |
| Disease | helix rolling | 1.31e-03 | 8 | 205 | 2 | EFO_0007670 | |
| Disease | Leukemia, Myelocytic, Acute | 1.36e-03 | 173 | 205 | 6 | C0023467 | |
| Disease | Nonorganic psychosis | 1.37e-03 | 69 | 205 | 4 | C0349204 | |
| Disease | Large cell carcinoma of lung | 1.41e-03 | 32 | 205 | 3 | C0345958 | |
| Disease | Endometrial Carcinoma | 1.61e-03 | 72 | 205 | 4 | C0476089 | |
| Disease | Major Depressive Disorder | 1.62e-03 | 243 | 205 | 7 | C1269683 | |
| Disease | brain measurement, neuroimaging measurement | CYRIA GNA12 PLEC SETD3 RNF135 ACTRT2 DENND3 ACTR1B PRKCZ FGD6 DNAH11 | 1.71e-03 | 550 | 205 | 11 | EFO_0004346, EFO_0004464 |
| Disease | sexual dimorphism measurement | KCTD13 ETFDH ETV6 TSC2 SNX13 FANCC GNA12 PLEC LILRA5 PDCD6 KCTD19 TUT7 RNF135 CEP164 GAL TNKS METTL15 | 1.94e-03 | 1106 | 205 | 17 | EFO_0021796 |
| Disease | level of Phosphatidylcholine (16:0_20:3) in blood serum | 2.08e-03 | 10 | 205 | 2 | OBA_2045075 | |
| Disease | Unipolar Depression | 2.32e-03 | 259 | 205 | 7 | C0041696 | |
| Disease | T-cell acute lymphoblastic leukemia (is_implicated_in) | 2.54e-03 | 11 | 205 | 2 | DOID:5603 (is_implicated_in) | |
| Disease | risk-taking behaviour | GABRG3 RYR2 ASCC3 PARPBP ANKRD52 IQCH NTRK2 RNF135 FIGN TNKS PRKCZ METTL15 EP300 | 2.79e-03 | 764 | 205 | 13 | EFO_0008579 |
| Disease | Alcoholic Intoxication, Chronic | 2.80e-03 | 268 | 205 | 7 | C0001973 | |
| Disease | colitis (biomarker_via_orthology) | 3.11e-03 | 42 | 205 | 3 | DOID:0060180 (biomarker_via_orthology) | |
| Disease | colorectal cancer | ABCC4 ETV6 HPGD PYGL GNA12 SETD3 SBNO2 ACTR1B LRIG1 GOLGA8A PCNT | 3.51e-03 | 604 | 205 | 11 | MONDO_0005575 |
| Disease | Thyroid carcinoma | 3.55e-03 | 44 | 205 | 3 | C0549473 | |
| Disease | illegal drug consumption | 3.56e-03 | 13 | 205 | 2 | EFO_0005431 | |
| Disease | leukemia (is_implicated_in) | 3.56e-03 | 13 | 205 | 2 | DOID:1240 (is_implicated_in) | |
| Disease | eosinophil count | GIMAP4 RASGRP4 CCDC18 SVEP1 AK3 MDN1 GNA12 VAV3 PLEC GPLD1 NAGK UBD HECTD4 SESN3 SBNO2 ACTR1B CD28 PDE8B STYXL1 ARHGAP45 | 3.76e-03 | 1488 | 205 | 20 | EFO_0004842 |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 3.78e-03 | 45 | 205 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | fibrinogen measurement, plasminogen activator inhibitor 1 measurement | 3.78e-03 | 45 | 205 | 3 | EFO_0004623, EFO_0004792 | |
| Disease | urate measurement | PDZK1 ZNF318 GRAMD4 AK3 STAB1 VPS51 ANKRD52 HSP90AB3P MOK HECTD4 GBA3 SLC12A1 CEP89 LRP2 | 4.11e-03 | 895 | 205 | 14 | EFO_0004531 |
| Disease | Adenocarcinoma of large intestine | 4.57e-03 | 96 | 205 | 4 | C1319315 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 4.75e-03 | 15 | 205 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 4.75e-03 | 15 | 205 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 4.75e-03 | 15 | 205 | 2 | C0154091 | |
| Disease | prostate cancer (is_marker_for) | 4.77e-03 | 156 | 205 | 5 | DOID:10283 (is_marker_for) | |
| Disease | Psychotic Disorders | 5.47e-03 | 101 | 205 | 4 | C0033975 | |
| Disease | major depressive disorder (is_marker_for) | 6.10e-03 | 17 | 205 | 2 | DOID:1470 (is_marker_for) | |
| Disease | autosomal dominant intellectual developmental disorder (is_implicated_in) | 6.10e-03 | 17 | 205 | 2 | DOID:0060307 (is_implicated_in) | |
| Disease | ceramide measurement | 6.17e-03 | 235 | 205 | 6 | EFO_0010222 | |
| Disease | left ventricular diastolic function measurement | 6.32e-03 | 54 | 205 | 3 | EFO_0008204 | |
| Disease | Metastatic melanoma | 6.32e-03 | 54 | 205 | 3 | C0278883 | |
| Disease | serum metabolite measurement | GABRG3 ABCC4 MYH10 MYO1E TRIO ETFDH NTRK2 SYT6 ATP10D GBA3 GAL CEP89 DOCK7 AKR1C3 | 6.55e-03 | 945 | 205 | 14 | EFO_0005653 |
| Disease | Antithrombotic agent use measurement | 6.65e-03 | 55 | 205 | 3 | EFO_0009925 | |
| Disease | Carcinoma of bladder | 6.83e-03 | 18 | 205 | 2 | C0699885 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HRAARDGYLELLKEA | 6 | Q495M9 | |
| FHGRLLFLKDVLGDE | 206 | Q8WZ19 | |
| EVTKLAIEAGFRHID | 36 | P17516 | |
| GRDAFLTLARDKHLE | 1626 | Q09472 | |
| TFADERGRLKDEIIH | 566 | Q8NDM7 | |
| STQAFDEHLKRLFER | 1196 | Q8NDM7 | |
| IHGEAFARRALAKID | 311 | Q96N23 | |
| ALFDFLKHRFDGRIS | 251 | Q02641 | |
| LFSREFRASLHKGLD | 46 | P10747 | |
| LFSDESERIVKAHGL | 216 | Q9BXI3 | |
| SERIVKAHGLDRFFE | 221 | Q9BXI3 | |
| RGHLFLREEVAKFLS | 136 | Q96QU6 | |
| TLFHGLDDRLLKELE | 306 | Q8TDY3 | |
| EVTKLAIEAGFRHID | 36 | P42330 | |
| LLRASGVHRIDAEEK | 186 | Q9H175 | |
| RTEFDRLNEIKGHLE | 71 | Q6IC98 | |
| RKDHSRFGILEFISI | 86 | P31371 | |
| LLLRKEGVDFHTSAE | 196 | P42025 | |
| ERLHRALKGIGTDEF | 256 | P12429 | |
| FNLEKARLEVHRFGI | 166 | Q8NDD1 | |
| LEKLLERFSQGSHRD | 4001 | Q96DT5 | |
| DHGIRRLTFLVAQKD | 1321 | Q13085 | |
| HISKVLFGEDDSLLR | 526 | Q92560 | |
| LDVRDHKGRTALFLA | 611 | Q8NB46 | |
| LDHDAFVLCRDFKGR | 741 | Q8NB46 | |
| FYDEHTLRKRGLLVA | 136 | Q96DB9 | |
| GIVKDASIIHRLFEA | 661 | A2RUS2 | |
| ALFDFLKHRFDGRIS | 241 | O00305 | |
| EDLDVLGLTFRKDLF | 66 | P49407 | |
| DLSRFRGFLEHSNKE | 251 | Q9P241 | |
| LLGARLKELEQEAHF | 456 | Q7Z5Q5 | |
| DRLGILTHLYRDFDK | 196 | Q9UJ70 | |
| LLEEHEATFGEKRFL | 56 | O75901 | |
| ADKLAREHGIRFFET | 136 | P51153 | |
| DVERHFSLGELKELF | 651 | Q92698 | |
| GGIFSLLEHVEKFLR | 296 | Q86VS3 | |
| HRFGLRKDLASAILD | 116 | P52333 | |
| SDVRFEHFLLHREGK | 51 | P43631 | |
| VLEGSLDREKEAAHL | 196 | Q9Y5H2 | |
| LGREAFTDLKHAARE | 201 | Q9NWS1 | |
| VDLLAITGFKDDRHT | 866 | Q17RG1 | |
| GFFLRIEKDTEGHLV | 21 | Q5T2W1 | |
| RLIIHRLKADDDGIY | 396 | O75147 | |
| DFKQSRLSEDGLHRE | 286 | P41212 | |
| ALAKEFAEILHFTLR | 126 | Q9H0Q0 | |
| FAEILHFTLRFDELK | 131 | Q9H0Q0 | |
| GEAEKIIHASFLVAR | 561 | Q5HY92 | |
| VEELGFERFHALIQK | 141 | Q9H8M7 | |
| SDVRFEHFLLHREGK | 51 | P43627 | |
| LRFDRFILTEEGDHK | 166 | A6NI73 | |
| FERLQSGHLTKLLED | 4546 | Q9NU22 | |
| ISHLLADVARFAEGL | 116 | Q92619 | |
| EEGLASIHSVLFRKD | 366 | Q8NCT3 | |
| FKGLRSLRVLDLDHN | 351 | Q96JA1 | |
| RGFFREETDHLIKNL | 576 | Q9C0I1 | |
| GTHLDLIEAKFRVER | 756 | Q38SD2 | |
| EDALRHEAVLAALFG | 601 | Q9H8L6 | |
| EGVSHFFRELAEEKR | 46 | P02792 | |
| KHFSVEGQLEFRALL | 261 | Q58FF7 | |
| TSAVREELFKALGLH | 451 | Q8WVP7 | |
| QGRVKDLESLFHRSE | 146 | Q03252 | |
| TIIRGLLEDKNFHEA | 1681 | Q6ZU64 | |
| DGDFLEAVKRHILSR | 71 | P09529 | |
| LLELEKFEHQGSRTR | 1421 | Q9BY66 | |
| FELKHLSSGDLLRDN | 31 | Q9UIJ7 | |
| ELRHLILKTAEGFLF | 181 | Q8WYA1 | |
| KRDAHRSLGIFDEQL | 156 | Q5T2Q4 | |
| LSDQFHDILIRKFDR | 126 | O75340 | |
| DRKTRFIIHGFIDKG | 86 | P54315 | |
| HLEFGKTLLRDESLN | 631 | P16499 | |
| ERHHLEFGKFLLSEE | 626 | P35913 | |
| ADVLHATAFFLGKER | 621 | O95263 | |
| RKVSLLFDHLETGEL | 191 | Q8TDF6 | |
| LAKERDHFQDLRAAL | 61 | Q8TDM6 | |
| LDAVLERAFSLRKAH | 31 | Q8IW45 | |
| DCELKILDFGLARHA | 161 | O15264 | |
| GLSDHREITKDAFLE | 471 | Q14693 | |
| ELDEARLAGKELRFH | 301 | Q8IVB5 | |
| KRIHLRAEDALFFFV | 66 | O95166 | |
| IALKHGFDTLERLTG | 326 | Q96EN8 | |
| LGSEGVEEIKRHLFF | 316 | Q9UK32 | |
| FDKIEHSTFDGLDRR | 891 | P98164 | |
| LHEVVFDRKSGSLAL | 66 | Q9UQ07 | |
| HFARKDLSEADARIF | 46 | Q92985 | |
| AERITEFCHRFLEGK | 336 | P07237 | |
| SRIREAKLAGDHIEY | 181 | Q15070 | |
| EGFHKFVIDRARQDI | 3411 | Q9Y4D8 | |
| FHSLEDRIVKRFLLG | 321 | A6NJ78 | |
| RDFEGAVDLLDKLNH | 351 | Q8IYI6 | |
| LAGKEDSEHRLVLEL | 1351 | O95613 | |
| EALIHAILRAGDKDD | 436 | P14923 | |
| HTDRFLSLEGDRAKV | 256 | Q70UQ0 | |
| AALFTIHKGSIEDRL | 1041 | Q9Y2A7 | |
| LELNETGHKLLFRDR | 491 | Q9UG01 | |
| EFTDLGHRLDCLDLK | 101 | O75864 | |
| AFKVALLDVFREAHA | 746 | P25205 | |
| ILNRFSKDIGHLDDL | 821 | O15439 | |
| FERGLELHAKVTIFA | 231 | Q16134 | |
| IHADRKSVLEVEFLG | 2151 | Q9ULT8 | |
| DELERITKLFHFLGI | 2236 | Q9ULT8 | |
| LSRDFLLGHVDAESL | 286 | Q6TDP4 | |
| FSDILRREIQHFGVK | 186 | O14756 | |
| AITKLAEISHRLEGF | 1866 | Q96N67 | |
| GRAEKIRHFREFLDS | 31 | P49917 | |
| SGKLREHELNSLLFD | 1581 | Q9H799 | |
| EAAKRAITFHLDLFA | 241 | Q9H227 | |
| LFSGLHARSRKVEED | 11 | Q99928 | |
| ELGASKVREAHLEAR | 1191 | Q5T9S5 | |
| LFIIDEKTGDIHATR | 101 | Q9Y6N8 | |
| FRHLSKEESLNIEGL | 336 | Q96ST8 | |
| FLHLKEAGALDRLLD | 96 | P22466 | |
| RIEDFGLHFVRESIK | 196 | Q9BT40 | |
| GVLSHILSALRFDKE | 116 | Q00597 | |
| HFRVAKSFDAVLEAL | 286 | Q6P1N0 | |
| TFEELEKHLGRVNFL | 66 | Q8N4T8 | |
| RLLALFDDRKNELAH | 326 | Q96C10 | |
| HGREFDQKALLEFRD | 81 | Q03113 | |
| DLRVARAEFGKNLIH | 146 | Q9UQ10 | |
| TLGDVHDFLLRLFLD | 81 | P22830 | |
| GRLNEKHDFLALELV | 1556 | Q9NYQ7 | |
| TSDAEFLERLHLFLA | 96 | Q8ND90 | |
| LDFLHSRGLVHADVK | 151 | P0C264 | |
| GAASEEELHLSRKLF | 2631 | Q92736 | |
| HGEDALLAAREVFKT | 46 | P43246 | |
| KHFSVEGQLEFRALL | 326 | Q14568 | |
| SKIFFRAGVLAHLEE | 766 | P35580 | |
| LEHGTVLFARLFALE | 21 | Q9NPG2 | |
| ESALRALREKLFAHS | 556 | O14830 | |
| ILLTHDGRVKLSDFG | 446 | O96013 | |
| TLRKFLFDLDVDDGL | 406 | Q8IWW8 | |
| EFVFLLKGHEDLRQD | 2181 | P42345 | |
| LDRLSGKILHIDFGD | 2346 | P42345 | |
| LRDTFRKVVDHFGRL | 71 | P15428 | |
| IDRDGKAFRHILNFL | 26 | Q693B1 | |
| LRVALEHGFRLDSVF | 201 | Q693B1 | |
| ADLREHVEKLELGFI | 456 | A7E2F4 | |
| DDTFRDLGNLTHLFL | 171 | Q9BZR6 | |
| LRHFFLVEDLVDSLK | 446 | O75298 | |
| ELADRKLHLSVFDFD | 306 | Q5T7P8 | |
| AHALELRKGELRSAD | 71 | Q9NP81 | |
| IVDDFGTHLRVFRKA | 161 | Q9Y5W8 | |
| IERLKSELHLLDFQG | 116 | Q9Y3A2 | |
| DKFLGRAEVDLRDLH | 101 | Q6WKZ4 | |
| DTAAGKIRDILHDLE | 191 | Q8IUD6 | |
| KLHDERVLVAFGQRD | 41 | Q9Y296 | |
| LFELIRKGELHFENA | 331 | Q9BYT3 | |
| FAEVLAREKRGEHLS | 266 | Q496J9 | |
| HRSKEGLTERFELFV | 476 | Q15046 | |
| HSDKREDLLIISSFF | 916 | Q5JRA6 | |
| LIFTRKDDLGDTNLH | 151 | Q9NUV9 | |
| RFLFRGLDTLTHVDL | 141 | Q8N135 | |
| DENFILKHDRAFLLS | 96 | P30414 | |
| FADGERKVEHLAVRF | 1426 | P0DJD1 | |
| ISIAAKDALERHFGE | 221 | P28069 | |
| RKAAEELLGSLEIDH | 751 | Q9Y2K3 | |
| AKRELRFLLVYLHGD | 166 | Q96CS3 | |
| RIHREEDFQFILKGI | 331 | Q8IV36 | |
| RHAIYDKLDDDGLIA | 841 | P30876 | |
| KEHLLGDSAIDRIFT | 396 | Q86TU7 | |
| GFRNESDREKFVHRL | 201 | Q92187 | |
| FRIKFADIHIIGDIN | 966 | Q13621 | |
| RNFEEFLHAIEKRGV | 446 | Q9Y2G9 | |
| FLRDLGHVETIFDCK | 386 | Q8IZU2 | |
| TLEDFKFLAVLGRGH | 611 | Q16512 | |
| RKFVVLFTDDLGHIS | 91 | Q8WUT9 | |
| LHSFEEFEALARRAL | 246 | Q4LDE5 | |
| HFLLERAIRADFALV | 196 | Q9BYC2 | |
| RLHSIEAILGFTKDD | 31 | Q9Y2V3 | |
| FLSDDELKHLILRAA | 141 | O00327 | |
| ELKHLILRAADGFLF | 146 | O00327 | |
| EATKLAIEAGFRHID | 36 | Q04828 | |
| ATLLFEGDREKVLQH | 466 | O00116 | |
| LDFGFRSRISEHLLD | 411 | Q9UPV0 | |
| AGYEHELSSLLREKR | 826 | Q9UPV0 | |
| AGLHERDRKTVEELF | 1621 | Q8N3C0 | |
| LRLGHKCFLLSRDFE | 181 | Q9Y240 | |
| LLRERAIFKVHSDFT | 376 | O75153 | |
| SKIFFRTGVLAHLEE | 766 | P35749 | |
| ARKDFHREAELLTNL | 581 | Q16620 | |
| ILHRDLKLGNFFITE | 181 | Q9H4B4 | |
| EFLAHARGRLEKELR | 271 | Q9UID3 | |
| FLVESGDEAKRHLLQ | 91 | O15205 | |
| LTFFHRGLLKEAIES | 291 | Q8NBP0 | |
| SFDKLLSHRDGLEAF | 86 | Q9NS28 | |
| LSHRDGLEAFTRFLK | 91 | Q9NS28 | |
| QRDKLGHILEEFATL | 446 | Q5VZE5 | |
| FAGDADKLLHIRIED | 201 | Q9Y6J8 | |
| RTDFLEATGLDLLHL | 426 | O94991 | |
| LADLFRQHEIDGKAL | 651 | Q9UQR0 | |
| DLIRHFLIESSAKGV | 506 | Q8IZW8 | |
| RLYSDIGHLLDEKFR | 366 | P58005 | |
| LHRRALEAKDIFAVE | 521 | Q9NXL6 | |
| QHFRKASEFLDEALL | 201 | Q5VZP5 | |
| LQRKHEGFERDLAAL | 1271 | Q13813 | |
| KSLGLEHLRDIFETE | 1036 | O95271 | |
| ALSRRQGEDFLLHKS | 191 | A6NJL1 | |
| FVDVLKLLHIDFRDA | 886 | Q6ZV73 | |
| LRAKDFVFSLLGLVH | 61 | Q8N9M5 | |
| LDLDKEAHRILEGFQ | 431 | P80108 | |
| ALSRRQGEDFLLHKS | 191 | Q9BUG6 | |
| RFLEALNHFEKARTL | 591 | P53804 | |
| HSLLEFDRIAEIIKG | 361 | Q9UJ04 | |
| GLELLRDKHASFFSL | 1586 | Q9NY15 | |
| VSLAAGHKFDRDVEL | 216 | O00534 | |
| FDTVLELARFLVKSH | 141 | Q2KHR2 | |
| VGLDLLHFALAEADR | 56 | Q86XW9 | |
| RGLHQSIEEFRAKIE | 696 | Q15149 | |
| KDRHDLIAGIDEFLD | 361 | Q9Y6R1 | |
| IVKFFHLRSGLEVDI | 1106 | Q5VYS8 | |
| KHSVLDVERLGRDDF | 276 | Q7L8A9 | |
| ADAHRSIEKFGIRLL | 211 | Q9NRD5 | |
| KLHSFLGDDVFLREL | 521 | P06737 | |
| LHVDQSREAGFKRLL | 1401 | Q92547 | |
| LDLKHEREAFFTLFD | 291 | Q6ZVT0 | |
| LRIVGERLFESKEGH | 66 | Q8N7K0 | |
| SFLLDGLHEDLNRVK | 406 | P51784 | |
| DLKAEGPERHTDFLL | 481 | Q5VUA4 | |
| IDTFFEDLKQRLGHR | 2076 | O75962 | |
| LHERLEVFKALTDNG | 136 | P49815 | |
| KRDERAGLFIHKEDA | 36 | B1ANS9 | |
| ILTRDGFFHIAENRK | 721 | Q9UKW4 | |
| FHEVGKDFLSSLRLL | 166 | Q68DI1 | |
| TLLELEKAERHGSRA | 1436 | P41229 | |
| FLHERGIIYRDLKLD | 366 | Q05513 | |
| TRDALAKALHARVFD | 351 | Q12965 | |
| AKALHARVFDFLVDS | 356 | Q12965 |